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Executive Summary
Screening for Distress in Ambulatory Oncology Patients: The COPE Project
Problem
Approximately 1.6 million new cancer cases are expected to be diagnosed in 2012
(American Cancer Society, ACS, 2012). Recent studies have found that 20-50% of newly
diagnosed and recurrent cancer patients demonstrate a significant level of distress (Carlson,
Waller & Mitchell, 2012; Mitchell et al., 2011; Swanson & Koch, 2010). Unfortunately less than
half of distressed patients with cancer are identified and referred for psychosocial help (KadanLottick, Vanderwerker, Block, Zhang & Prigerson, 2005). Elevated levels of distress in cancer
patients has been associated with decreased adherence to treatment, difficulty making treating
decisions, extra medical visits, poorer quality of life, and greater stress for the oncology team
(Fann, Ell, & Sharp, 2012). The National Comprehensive Cancer Network (NCCN, 2012)
recommends that all patients be screened for distress at their initial visit, at appropriate intervals,
and as clinically indicated. Based upon this recommendation, the following evidence-based
project about the population, intervention, comparison, and outcome (PICO) was developed:
Will oncology patients receiving care in a rural ambulatory infusion center who participate in a
comprehensive psychosocial assessment program experience a decrease in distress levels?
Purpose
The purpose of this Doctorate of Nursing Practice (DNP) Capstone Project was to
identify, assess, and refer patients who are experiencing an elevated level of distress as measured
by the NCCN Distress Thermometer.
Goal
The goal of this project was to decrease the psychosocial distress level in patients
receiving chemotherapy.
Objective
The primary objective of this evidence-based practice project was to decrease distress in
oncology patients. The secondary objective was to formally adopt the NCCN clinical practice
guidelines for distress management in ambulatory oncology patients.
Plan
The NCCN Distress Thermometer (DT) was utilized to measure the distress level of
ambulatory oncology patients currently receiving chemotherapy in an outpatient infusion center.
The capstone project received Institutional Review Board approval from Regis University as
well as the New England Institutional Review Board and met exempt status.
Outcomes and Results
A total of 21 ambulatory oncology patients participated in this project. The majority of
patients (57%) presented with clinical evidence of moderate to severe distress as evidenced by a
distress score of >4. Physical problems were the most frequently identified source of distress.
Data analysis revealed an overall decrease in distress scores. However, there was not a
statistically significant difference in individual distress scores. The NCCN Distress
Thermometer facilitated the identification, assessment, and treatment of distress in ambulatory
oncology patients. As a result of this project, the NCCN Distress Management clinical practice
guidelines have been formally integrated into routine nursing assessments.
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Problem Recognition and Definition

Approximately 1,638,910 new cancer cases are expected to be diagnosed in 2012
(American Cancer Society, ACS, 2012). Recent studies have found that 20-50% of newly
diagnosed and recurrent cancer patients demonstrate a significant level of distress (Carlson,
Waller & Mitchell, 2012; Mitchell et al., 2011; Swanson & Koch, 2010). Unfortunately less than
half of distressed patients with cancer are identified and referred for psychosocial help (KadanLottick, Vanderwerker, Block, Zhang & Prigerson, 2005). Elevated levels of distress in cancer
patients has been associated with decreased adherence to treatment, difficulty making treating
decisions, extra medical visits, poorer quality of life, and greater stress for the oncology team
(Fann, Ell, & Sharp, 2012). The National Comprehensive Cancer Network (NCCN, 2012)
recommends all patients be screened for distress at their initial visit, at appropriate intervals, and
as clinically indicated.
Purpose

The purpose of this Doctorate of Nursing Practice (DNP) Capstone Project was to
identify, assess, and refer patients who are experiencing an elevated level of distress as measured
by the NCCN Distress Thermometer.
PICO

The Population, Intervention, Comparison, Outcome (PICO) acronym was utilized as the
framework to form the practice question and facilitate a systematic review of the literature.
Population: Oncology patients receiving care in a rural ambulatory infusion center
Intervention: Implementation of the NCCN Distress Management guidelines
Comparison: There is no comparison group
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Outcome: Decrease in distress scores as measured by the NCCN Distress Thermometer (DT)
instrument.
As a result of this Capstone Project, the following PICO question will be answered: Will
oncology patients receiving care in a rural ambulatory infusion center who participate in a
comprehensive psychosocial assessment program experience a decrease in distress levels?
Project Significance, Scope and Rationale

The role of the doctorate-prepared advanced practice nurse is to bring evidence to patient
care (Zaccagnini & White, 2011). According to Zaccagnini & White (2011), “every advanced
practice nurse should be a nurse scientist, gathering evidence at the patient’s side, making
observations, having experiences, responding to the patient’s experiences, and thinking about
reasons, theories, or concepts that might organize the evidence” (p.8). In order to reduce the
burden of cancer and treatment-related suffering, the author felt it was imperative to implement
an evidence-based, interdisciplinary clinical practice guideline that will address the psychosocial
needs of oncology patients. In 2008, the Institute of Medicine (IOM) recommended effective
psychosocial care be an integral part of quality cancer care. The committee specifically
recommended the use of tools and strategies to improve patient-provider communication;
facilitate the identification and assessment of psychosocial health problems, and to design illness
and wellness management strategies (IOM, 2008).
Theoretical Foundation

Kolcaba (2010) provided a unique description of comfort in health care. She described
comfort as “the immediate state of being strengthened by having the needs for relief, ease, and
transcendence addressed in the four contexts of holistic human experience: physical,
psychospiritual, sociocultural, and environmental” (Introduction section, para.1). Kolcaba’s
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comfort theory can be utilized to determine the existence and extent of unmet needs, designing
interventions, and creating measurements of holistic comfort for documentation in practice and
research (Kolcaba, as cited in Parker & Smith, 2010). This is particularly relevant to the DNP
practice issue because the NCCN distress thermometer addresses the same domains: physical
symptoms, spirituality, practical issues, family problems, and spiritual/religious concerns.
Although the concept of comfort is not unique to nursing, Kolcaba has developed a
middle-range nursing theory that encourages nurses to define their unique contribution to patient
care outside of the biomedical model. According to Kolcaba (2001), nurses are the ones
primarily responsible for identifying and assessing the comfort needs of patients who experience
a stressful life event. The comfort theory states the process of comforting a patient entails the
intention to comfort, to be present, and to deliver comforting interventions based on the patients’
and loved ones’ unmet needs (Kolcaba, as cited in Parker and Smith, 2010).
The major concepts identified in Kolcaba’s comfort theory (2001) are: the identification
of health care needs, comfort interventions, intervening variables, health-seeking behaviors, and
institutional integrity. Kolcaba (1991) originally described three technical senses of comfort:
state, relief, and renewal. These were later described as relief, ease, and transcendence (Kolcaba,
2001). All of these concepts are related to the outcome of comfort and can be measured in terms
of both patient comfort and family comfort.
Health care needs are defined as the need for comfort that cannot be met by the patients’
traditional support system (Kolcaba, as cited in Parker & Smith, 2010). These needs encompass
physical, spiritual, sociocultural and environmental needs that are identified by patients and
nurses. In the context of the DNP practice issue, health care needs may include practical
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problems (e.g., child care, housing), family problems, emotional problems, spiritual/religious
concerns, and physical problems such as appearance, fatigue, nausea, and pain.
Literature Review

The goal of evidence-based practice is to promote optimal healthcare outcomes which are
based on critically reviewed clinical evidence as well as the preferences and values of patients
and families (Chism, 2013; Eaton & Tipton, 2009). Implementing evidence-based practice
(EBP) at the bedside remains a formidable challenge for the majority of nurses. Successful
implementation requires a multi-step process including: identifying the problem, formulating a
question, finding the evidence, critically appraising and synthesizing the evidence; translating the
evidence into practice; and evaluating the EBP change (Houser & Oman, 2011). Evidence-based
oncology nursing practice is largely driven through the advancement of innovative scientific
research on cancer treatment, supportive care, and promising patient outcomes. An
overwhelming amount of data is available to help nurses manage cancer symptoms and side
effects. The author has completed a systematic review of the literature in order to identify,
select, assess, and summarize similar studies (see Appendix A). Several databases were searched
including: CINAHL, MEDLINE, PsycINFO, and the Cochrane Library.
Psychosocial distress was the first key term searched within CINAHL and resulted in
7,093 articles. The search was narrowed by adding the term ‘cancer’ and this resulted in 1,815
articles. Finally, ‘distress thermometer’ was added to psychosocial distress and cancer resulting
in 54 articles. A duplicate search was completed in MEDLINE and resulted in an initial 4, 171
articles which were narrowed to 1,261 and finally 52 articles. The PsycINFO database revealed
an initial 5,280 articles which was narrowed to 982 articles and finally 35 articles. The Cochrane
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Library search revealed an initial 26 articles and was narrowed to 11 articles. After the term
‘distress thermometer’ was added to the search list, only one article was identified.
The National Comprehensive Cancer Network (NCCN) defines distress as a
“multifactorial unpleasant emotional experience of a psychological (cognitive, behavioral,
emotional), social and or/spiritual nature that may interfere with the ability to cope effectively
with cancer, the physical symptoms, and its treatment” (NCCN, 2012, p. DIS-2). The term
“distress” was chosen because it was felt to be less stigmatizing than “psychiatric”,
“psychosocial” or “emotional” (NCCN, 2012). Distress symptoms can vary greatly from
common feelings of vulnerability, sadness, and fear to problems including severe depression and
anxiety that are disabling and require professional intervention (Fitch, 2011). Patient risk factors
for distress include: a diagnosis of lung, brain, or pancreatic cancer, disability, and ongoing
unmet needs (Carlson, Waller, & Mitchell, 2012; Keir, Calhoun-Eagan, Swartz, Saleh, &
Friedman, 2008; Steinberg et al., 2009). Hurria et al. (2009) also found that poor physical
function and age (>65) were predictors for elevated distress. Oncology patients residing in a
rural area may also have an increased risk for distress (Smith, Limesand, & Alikhan, 2011).
Screening for distress as an integral part of psychosocial care has become a major priority for
numerous professional organizations as well as cancer treatment centers (Jacobsen & Wagner,
2012).
Due to the potential negative impact on patient outcomes, all patients with cancer should
be screened for evidence of psychological distress as part of routine care (Holland & Alici, 2010;
Jacobsen, Holland, & Steensma, 2012). However, it has been noted that the process of
identifying those needs and rendering the appropriate intervention and/or referral requires an
assessment tool that can quickly yet effectively identify patients who are experiencing elevated
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levels of distress (Carlson et al., 2012). In an effort to meet this need, Roth et al. (1998)
developed a “distress thermometer” that could be administered and interpreted rapidly by clinical
staff. Patients who complete this assessment are asked to rate their distress using a scale with
scores ranging from 0 (no distress) to 10 (extreme distress). This screening tool also has a
problem checklist that highlights five potential areas of difficulty that may be linked to distress:
practical, family, emotional, spiritual, and physical. Patients with a score of less than four are
considered to have “mild” distress and can be managed by the primary oncology team. Patients
with a score of four or greater are considered to have moderate to severe distress and should be
referred to the appropriate professional (social worker, chaplain, psychologist, or other specialist)
(NCCN, 2012). The National Comprehensive Cancer Network (2012) provides a structured
algorithm that guides the clinician in making the appropriate referral based upon the patients’
level of distress. The goal of this assessment tool is not to identify all potential psychiatric
disorders but rather to target and offer appropriate referrals for the most common sources of
distress such as insurance/financial issues, fatigue, pain, nausea, and spouse/child problems
(Holland & Alici, 2010).
Mitchell (2010) completed a review and diagnostic validity meta-analysis for cancerrelated distress screening tools. A total of 45 potentially useful short and ultra-short tools tested
and utilized within cancer and palliative care settings were identified. Only three of these tools
had been tested against robustly defined distress (i.e., distress defined by semi-structured
interview) in multiple samples (Mitchell, 2010). Only the Distress Thermometer (DT) and a
single verbal question (1Q) were specifically validated against interview-defined distress in more
than one independent sample. The DT was found to have a sensitivity of 78.5% and a specificity
of 67.4% in multiple independent samples (Mitchell, 2010). Vodermaier, Linden, & Siu (2009)
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also completed a systematic review of tools used to screen patients for emotional distress. The
authors concluded the DT had a moderate level of reliability (Cronbach’s alpha >0.60 and <0.80)
and a moderate level of validity (average sensitivity and specificity <0.6 and <0.8). The Distress
Thermometer Tool has been identified as an ultra-short, valid, and reliable screening tool that is
inexpensive and easy to adopt in a clinical setting (Fulcher & Grosselin-Acomb, 2012; Hoffman,
Zevon, D ’Arrigo, & Cecchini, 2004; Jacobsen et al., 2005; Kendall, Glaze, Oakland, Hansen, &
Parry, 2011; Lowery & Holland, 2011; Shimizu et al., 2010; Snowden et al., 2011; Vitek,
Rosenzweig, & Stollings, 2007).
Despite the availability of valid and reliable oncology-specific screening tools, screening
for distress has not been widely adopted in clinical practice. Jacobsen & Ransom (2007)
reported only 53% of NCCN member institutions screen routinely for distress. A physician
survey completed by the American Society of Clinical Oncology (ASCO) reported 65% of
oncologists screen for distress; however, only 14% of these physicians reported utilizing a
standardized screening instrument. Furthermore, only 35% of respondents indicated they were
familiar with screening guidelines (Pirl, 2004). Mitchell, Lord, Slattery, Grainger, and Symonds
(2012) reported only a minority of clinicians ask their oncology patients about emotional
problems. Many clinicians preferred to rely on patients mentioning the problem during an office
visit. The authors also reported that only 15% of clinicians use a screening tool and most of the
clinicians preferred using their own clinical judgment (Mitchell et al., 2012).
Unfortunately limited data exists on the benefits of screening for emotional distress
within the oncology population. Carlson, Groff, Maciejewski, and Bultz (2010) implemented an
online distress screening program for new patients with breast and lung cancer. The primary
objective of the study was to compare the efficacy of screening on subsequent distress.
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Secondary objectives included measures of anxiety and depression and to assess the
impact of receiving referrals. Patients were randomly assigned to one of three groups: minimal
screening, full screening, and full screening plus triage with a referral to resources. Patients
randomized to the minimal screening group had the DT administered but no feedback was given
to the patient. Patients in the full screening arm completed the DT, the DT problem checklist,
fatigue and pain thermometers, and a test to measure anxiety and depression. Patients were
printed a personalized feedback report and a summary report was placed in the electronic
medical record. Patients randomized to the triage arm received all of the full screening plus they
received a referral to speak to a member of the psychosocial team. The mean baseline score for
all participants was high (4.33). Approximately 55% of all patients had a score of > 4 at the time
of study enrollment. Patients randomized to the triage group showed significantly lower distress
at three months compared with the minimal screening group (p=0.031). Patients over the distress
cutoff score was significantly lower in the triage group (36%) compared to the full screening
(46%) and minimal screening group (48.7%) (Carlson et al., 2010). The authors concluded
intensive screening including feedback to patients and care providers followed by an appropriate
referral helped to reduce future distress levels (Carlson et al., 2010).
Frost, Zevon, Gruber and Scrivani (2011) utilized the NCCN DT tool to measure the
level of distress in head and neck cancer patients receiving chemotherapy in an ambulatory care
clinic. A total of 763 patients participated in the pilot study. Approximately 19% of all patients
had a score of four or higher on the 10-point DT scale; indicating a moderate to severe level of
distress. The most frequently reported physical symptoms were fatigue (29%), pain (21%), sleep
(20%), and eating difficulties (13%). Emotional problems included worry (24%), nervousness
(19%), and both depression and fearfulness (11%). The authors concluded that early use of the

Cancer-Related Distress

9

DT helped to identify post-hospital placement, individual or family counseling needs, and
financial issues. Furthermore, this pilot study demonstrated that the DT placed minimal burden
on the nursing staff and was easy to implement in an outpatient clinic setting.
Psychological distress among women with newly diagnosed breast cancer has also been
studied. Mertz et al. (2012) utilized the DT to determine the characteristics and extent of
psychological distress among women at the time of their breast cancer diagnosis. A total of 343
women completed the distress thermometer. When a score of three on the DT was used as the
cut-off, 77% of women were categorized as experiencing distress.

The results displayed a

significant inverse association between distress and age; higher age was associated with lower
distress with an odds ratio (OR) per year of 0.96, 95% CI [0.93, 0.98]. Worry (77%) and
nervousness (71%) were the most frequently reported problem areas, followed by sleep
disturbances (50%), fatigue (49%), and sadness (45%). The authors did not find a significant
association between distress levels and the presence of a partner or family support.
Fulcher and Gosselin-Acomb (2007) completed a feasibility pilot study utilizing the
distress thermometer in a radiation oncology center. A total of 57 patients completed the distress
thermometer during a three month pilot study. The mean baseline distress thermometer score
was 2.2. Eight patients had an increase in their distress score over the course of their treatment
and 11 patients had a decrease in their score. All other patients had no change in their distress
scores over time. The authors did note social worker, chaplain, and mental health referrals
increased during this period. Furthermore, the authors noted that patient satisfaction scores were
higher post-implementation (88.1% vs. 92.6%). Due to the sample size this particular study did
not reach statistical significance. However, it can be argued that clinical significance was
reached for several of these patients as well as the institution as a whole.
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O’Sullivan, Bowles, Jeon, Ercolano, and McCorkle (2011) studied the impact of
advanced practice nursing (APN) interventions on the level of psychological distress during
ovarian cancer treatment. The authors hypothesized women with suspected ovarian cancer who
received a specialized nursing intervention program would have greater improvement in quality
of life measures over time compared to women in an attention-control group. The use of the
distress thermometer found that 24 of 32 women reported high levels of distress. Participants
were divided into three subgroups: High distress/oncology APN plus referral to psychiatric
APN, High distress/oncology APN only/refused psychiatric APN, and low distress/oncology
APN only. There was no statistical difference in the mean number of total problems per contact
in each of the groups. However, the findings did indicate that women with high levels of distress
who received care from both an oncology APN and a psychiatric APN required fewer
interventions per contact.
Hammonds (2012), a DNP student at the University of South Alabama, utilized the DT
tool to identify elevated levels of distress in breast cancer patients receiving treatment at a
university breast cancer clinic. A total of 104 patients participated in this quality improvement
project. Patients with a DT score of > 4 were referred to a psychiatric mental health practitioner,
social worker, chaplain, dietician, primary care provider, or oncologist. During the project 55%
of participants were identified as experiencing a moderate or severe level of distress. The author
concluded the DT is a brief and effective tool for identifying distress in oncology patients.
Swanson and Koch (2010) completed a retrospective chart review to collect information
about whether or not the utilization of an oncology nurse navigator (ONN) would result in a
decreased distress score for adult inpatients. The authors found that patients seen by the ONN
tended to have lower distress scores on dismissal but this was not statistically significant
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(p=0.1046). However, there was a statistically significant effect on patients 65 years of age or
younger (p=0.044) as well as patients from rural settings (p=.045). Skrutkowski et al. (2008)
also examined the impact of an oncology nurse navigator on patient distress levels. Patients with
lung or breast cancer were assigned to an intervention group with care by a ‘pivot nurse’ in
oncology and usual care by clinic nurses or to a control group with usual care only. Participants
in both groups were assessed for symptom distress, fatigue, quality of life, and healthcare
resource usage. No significant difference was found in distress levels between the groups over
time (p=0.675). However, the results did demonstrate a statistical significance in distress over
time based upon the type of cancer. Patients with lung cancer had more distress than patients
with breast cancer (p=.023).
In addition to the data regarding the benefits of distress screening, several authors have
addressed the challenges of implementing a distress screening program in clinical practice.
Barriers include lack of coordinated evidence-based psychosocial services, financial
reimbursement, clinician training/expertise, screening time, resistance to change, and insufficient
resources (Absolom et al., 2011; Carlson et al., 2012; Dudgeon et al., 2012; Fann et al., 2012;
Fitch, 2011; Jacobsen, 2007; Jacobsen & Ransom, 2007; Madden, 2006; Mitchell, Vahabzadeh,
& Magruder, 2011; Pincus & Patel, 2009).
Oncology nurses can play a pivotal role in removing some of these barriers. Nurses must
have the knowledge and skills to rapidly and accurately assess the psychosocial needs of their
patients. Unfortunately many nurses have not received any formal education or training on how
to perform a comprehensive holistic patient assessment. Spade and Mulhall (2010) developed a
high-fidelity simulation exercise to teach undergraduate nursing students about the importance of
holistic nursing assessments. The Psychosocial Vital Signs (PVS) curriculum was developed to
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help nursing students learn how to gather cognitive, affective, spiritual, and behavioral data
about their patients (Spade & Mulhall, 2010). The simulation exercise allowed nursing students
the opportunity to identify and assess a patient’s level of anxiety, coping, and sense of support.
Nursing students were also taught how to devise, implement, and evaluate a patient-specific
treatment plan. Although this model has not been tested or validated in a clinical setting, it does
provide a conceptual framework for an innovative nursing curriculum designed to foster critical
thinking and improved communication skills for nursing students.
Pasacreta, Kenefick, and McCorkle (2008) described the “ICAN: Distress Management
for Oncology Nursing” online continuing education program designed to help oncology nurses
integrate distress screening into their routine patient assessments. Developed by the American
Psychosocial Oncology Society (APOS) and the Individual Cancer Assistance Network (ICAN),
this webcast is available to any nurse interested in understanding how to identify, assess, and
treat psychosocial distress in oncology patients. Content areas include: barriers to psychosocial
care, appropriate use of resources, goals and benefits associated with psychosocial intervention,
and psychosocial symptom management. This type of training program can help oncology
nurses learn more about the essential components of psychosocial oncology and alleviate some
of the traditional barriers to implementing a comprehensive distress management program.
Project Plan and Evaluation
Market/Risk Analyses

A comprehensive needs assessment was completed prior to project implementation. This
project was endorsed by the local Cancer Committee and is considered to be an integral part of
oncology care as defined by the National Comprehensive Cancer Network (NCCN) as well as
the American College of Surgeons (ACOS).
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While more than 577,190 Americans are expected to die of cancer in 2012, the survival
rate for many cancers continues to improve (ACS, 2012). The five-year survival rate for all
cancers diagnosed between 2001 and 2007 is 67%, a significant increase from 49% between
1975 and 1977 (ACS, 2012). Unfortunately many advanced cancers are not curable and these
patients will require extended periods of multi-modality treatment including numerous
chemotherapy regimens with or without radiation therapy. For many patients, cancer will
become a chronic disease which will require intensive surveillance and intermittent periods of
treatment. As a result, some patients will endure prolonged periods of physical, spiritual, and
emotional distress. These problems can adversely affect the quality of patients’ lives during their
initial chemotherapy as well as many years into survivorship. Unfortunately, these problems can
be magnified if a patient has any pre-existing psychological or social stressors that were present
prior to the cancer diagnosis (IOM, 2008).
Strengths/Weaknesses/Opportunities/Threats

A comprehensive strengths, weaknesses, opportunities, and threats (SWOT) analysis for
the DNP Capstone Project was completed (see Table 1). The project utilized an ultra-short,
validated distress assessment tool as well as a comprehensive treatment algorithm. This allowed
the advanced practice nurses (APN) the ability to rapidly identify a patient’s psychosocial needs,
develop an individualized plan of care, and make the appropriate referral for treatment. The
factors which might have impacted successful completion of the Capstone Project included the
following constraints: clinician training/expertise, competing priorities, attrition rate, and space
for privacy. Strategies to increase the likelihood of completion of the Capstone Project included
comprehensive staff education, scheduled appointments, collaboration with an interdisciplinary
team, and utilization of DNP Capstone mentors.
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Needs/Resources/Sustainability

The needs for the project included access to the patient population and their medical
record, cooperation from staff and physicians, and institutional review board approval.
Resources included the NCCN Distress Management clinical practice guidelines, statistical
analysis software, and interdisciplinary staff. Sustainability of this project is possible because
the distress thermometer tool has already been incorporated into the electronic health record
(EHR). Furthermore, the hospital cancer committee unanimously approved integrating this
comprehensive psychosocial assessment program into the existing oncology service line
program.
Feasibility/Risks/Unintended Consequences

Potential risks to this project include lack of acceptance and involvement by key
stakeholders, competing priorities, and a reluctance to accept new clinical practice guidelines for
distress management. This project may also reveal that patients are unsatisfied with their overall
oncology care.
Stakeholders

Stakeholders for this project included: patients, physicians, nurses, insurers, ancillary
staff, administrators, researchers, the American College of Surgeons (ACOS), the Joint
Commission (JC), the Center for Medicare and Medicaid Services (CMS), and community
agencies. The project team included Advanced Practice Registered Nurses (APRNs), infusion
nurses, physicians, social workers, chaplains, financial counselors, patient navigator,
administrators, and dieticians. Furthermore, additional support was provided by the DNP
Capstone Mentor and Regis University DNP Faculty and Capstone Chair.
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Table 1
SWOT Analysis
Strengths:
Endorsed by Cancer Committee
Respected, peer reviewed guidelines
Comprehensive treatment algorithm
Weaknesses:
Lack of formal referral process
Poorly coordinated psychosocial services
Clinician training/expertise
Paper-based assessment
Unfamiliarity of guidelines
Opportunities:
Decreased distress level
Improved provider communication
Improved patient satisfaction
Improved patient trust and rapport
Threats:
Competing priorities
Time constraints
Space for privacy
Attrition rate
Reimbursement

Proactive, holistic assessment
Ultra-short, validated tool
Interdisciplinary collaboration
American College of Surgeons (ACOS) Accreditation
Strategies to overcome:
Staff education
Develop a referral algorithm
Scan into EMR

Decreased hospitalizations
Increased quality of life
Impetus for new programs
Adoption of electronic tools
Strategies to overcome:
Integrate into chemotherapy education appointment
Utilize assistance of DNP Capstone Mentor
Use of participant letter
Scheduled appointments

Cost-Benefit Analysis

The costs and benefits of this project were determined prior to implementation. Direct
costs included labor and supplies. The average assessment time per patient was 30 minutes. At
an average cost of $55.00/hour x 84 assessments (21 participants x 4 assessments), the APRN
salary expense was approximately $2,310.00. Copier paper and supplies were approximately
$50.00. The Statistical Software Package for Social Sciences (SPSS) was $55.00. Indirect costs
of this project were minimal due to the use of existing space, internet access, and support staff.
The benefits of this DNP Capstone Project include: improved patient outcomes, enhanced
communication between providers and patients, improved patient satisfaction, improved staff
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retention, and enhanced institutional integrity. Furthermore, this project may identify current
gaps in oncology care at that can be filled by new programs and/or services.
Mission/Vision/Objectives

The mission was to nurture and improve the quality of life for people with cancer. The
goal of this project was the successful integration and application of the NCCN Distress
Management guidelines for oncology patients. The core values of the Capstone Project included:
comfort, compassion, respect, and collaboration. This DNP Capstone Project had a primary and
secondary objective. The primary objective was to decrease the distress level in oncology
patients receiving care in a rural ambulatory infusion center. The secondary objective was the
formal institutional adoption of the NCCN clinical practice guidelines into routine cancer care.
Evaluation Plan

The logic model (see Appendix B) addresses several advanced practice nursing outcome
measures including: care-related (cost of care, length of stay, readmission rates, office visits,
quality of life); patient-related (compliance, symptom resolution, functional status); and
performance-related (job satisfaction, performance ratings, collaboration, and quality of care).
According to Kleinpell (2009), these groupings can be used to examine outcomes studies of APN
care and help identify future research opportunities. The benchmark target is the incorporation of
a standardized tool to identify, assess, and refer patients experiencing a heightened level of
distress according to national practice guidelines. Patients appropriately screened and referred
for distress will experience a decrease in their overall emotional distress level.
In addition to the numerous potential patient benefits, this project fostered an
environment that supports interdisciplinary collaboration. The Institute of Medicine (2001)
emphasized the need for providers and institutions to actively collaborate and participate in care
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coordination in order to improve patient safety and patient health outcomes. The doctorateprepared advanced practice nurse should play a pivotal role in establishing these
interprofessional teams (American Association of Colleges of Nursing, AACN, 2006).

This

Capstone Project was the impetus to fostering a professional, collegial relationship with multiple
providers and stakeholders at Cheyenne Regional Medical Center.
Study Methodology/Instrumentation/Measurement

This evidence-based practice project consisted of implementing the National
Comprehensive Cancer Network (NCCN) guidelines for distress management in oncology
patients. All of the participants had a cancer diagnosis and were expected to receive
chemotherapy for at least three months. Additional inclusion criteria included the ability to
speak, read, and understand English and a baseline Eastern Cooperative Oncology Group
(ECOG) score of < 2. There were 21 participants in the study. The project started on February
19, 2013 and was completed May 17, 2013 (see Appendix C).
At their initial infusion center appointment patients were provided information on the
Comprehensive Oncology Patient Evaluation (COPE) project by the primary investigator or
assistant investigator for this project. All new patients were asked to participate. Furthermore,
all patients who had started chemotherapy within 30 days after Institutional Review Board (IRB)
approval were also asked to participate. New chemotherapy patients were provided information
about this project during their chemotherapy education session with an advanced practice
registered nurse (APRN). Patients were provided a participant letter at the time of their
education session (see Appendix D). Patients who already started their treatment (within 30 days
after the project had been approved) were asked to participate during one of their subsequent
infusions. All patients received extensive information about this project in a private, confidential
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office. Time was allotted for patients to ask questions and for the investigator to address any
concerns.
The patients were interviewed by either the primary investigator or assistant investigator
using the Ambulatory Infusion Center’s intake history and assessment forms. Both investigators
for this project were advanced practice registered nurses (APRNs) employed at the Ambulatory
Infusion Center. Patients were asked to complete the National Comprehensive Cancer Network
(NCCN) Distress Thermometer checklist. The Distress Thermometer (DT) is a paper and pencil
assessment took approximately five minutes to complete. Permission to utilize the DT had been
granted by the National Comprehensive Cancer Network (NCCN) (see Appendix E). The
Distress Thermometer instrument asked patients to rate their level of distress within the past
week on a scale of 0-10 (0=no distress; 10=extreme distress) and complete the problem check list
in each of the five areas linked to distress including practical, family, emotional, spiritual, and
physical (see Appendix F). The National Comprehensive Cancer Network (NCCN) Distress
Thermometer (DT) has a Cronbach’s alpha score of 0.86 (Moretz, 2002). A baseline DT
assessment was completed by patients at the time they began their chemotherapy infusion or
within 30 days of starting their initial infusion, and at least monthly during their chemotherapy
infusion visits. Patients with a distress score of > 4 were individually assessed by an advanced
practice registered nurse (APRN) and the appropriate referral was made based upon the
guidelines in the NCCN treatment algorithm (see Appendix G).
Protection of Human Rights

To protect against the breach of confidential information, the project primary investigator
assigned each chart a code number different from their medical record number. This code, not
the patients name, appeared on the chart audit data collection instrument form (see Appendix H)
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that contains data collected from the patient's chart. The patient names, along with their codes,
were stored in a locked file cabinet in the investigator’s office. The secondary investigator was a
registered nurse with Collaborative Institutional Training Initiative (CITI) certification, was
trained on the data collection processes for this project, and was supervised by the primary
investigator (see Appendix I). The New England Insititutional Review Board as well as the
Regis University Institutional Review Board approved this project (see Appendix J and K,
respectively). Furthermore, this DNP Capstone Project was approved by the hospital Chief
Compliance Officer (see Appendix L). Information was kept on a computer that is password
restricted. The demographic information was filed separately from the questionnaires and will be
destroyed five years after the close of the study.
Statistics

Data obtained from the chart audit was analyzed using the Statistical Product and Service
Solutions (SPSS) software package. The patient's distress scores were analyzed to determine if
there had been a decrease in their distress level. Descriptive statistics including frequencies,
means, standard deviations, and ranges were completed on demographic data, ECOG scores, and
distress scores. A repeated measures ANOVA was utilized to measure changes in distress scores
over time. Reliability testing on the NCCN DT instrument was also completed.
Project Findings and Results
Description of the Sample

A total of 21 ambulatory oncology patients participated in this project. See Table 2 for
demographic characteristics. The mean age was 63 (range 44 to 84 years). Patients with all
stages of cancer were included: stage I (5%), stage II (10%), stage III (29%), and stage IV
(48%). The primary goal of treatment was palliation (71%). The most common diagnoses were:
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lymphoma (23%), breast cancer (14%), pancreatic cancer (14%), lung cancer (10%), and
colorectal cancer (10%). The majority of participants (71%) had an ECOG score of one.
The majority of patients (57%) presented with clinical evidence of moderate to severe
distress as evidenced by a distress score > 4. The mean baseline score was 3.95 (SD, 3) and the
median score was four with a range of scores from zero to nine. Physical problems were the
most frequently identified source of distress during the initial assessment (19%). Participants
were primarily referred to the oncology nurse practitioner for symptom management (95%).
At the time of the second assessment, 29% of patients reported a moderate to severe level
of distress. The mean score for the second assessment was 2.52 (SD, 2). The median score was
two with a range of scores from zero to seven. Practical problems were the most frequently
identified source of distress during the second assessment (14%). Participants were referred to
the nurse practitioner (17%) or financial counselor (10%).
Only 16 participants completed a third assessment. Of the patients who completed the
third assessment, 38% of them had a distress score of > 4. Their mean score was 2.5 (SD, 3).
The median score was one with a range of scores from zero to nine. The majority of participants
reported physical problems (10%). Participants were again primarily referred to the nurse
practitioner for symptom management (20%).
The final assessment was completed by six participants. The other participants had
completed treatment, died, or had a delay in their treatment beyond the three month timeframe
allowed for this project. The mean score for the final assessment was 1.17 (SD, 2). Only one
participant had an elevated distress score of > 4. Demographic data for the six participants who
completed all four of the assessments were similar to the total population. The mean age was 67
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years (range 56-84). The goal of treatment was palliation (66%) and the most frequent diagnosis
was pancreatic cancer (40%). All of these participants had an ECOG score of 0-1.
Table 2
Demographic Characteristics
Characteristic
Gender
Male
Female
Ethnicity
Caucasian
African American
Marital Status
Married
Single
Widowed
Divorced
Employment Status
Retired
Full Time
Unemployed
Insurance
Medicare
Medicaid
Private
Uninsured
Living Situation
Alone
Spouse
Extended Family
Other
Religion
Catholic
Presbyterian
Lutheran
Christian
None
Other
Comorbidities
Yes
No
Treatment Goal
Palliative
Curative

Patients
No.
%
10
11

48
52

20
1

95
5

12
1
3
5

57
5
14
24

12
4
5

57
19
24

10
1
8
2

47
5
38
10

4
12
2
3

19
57
10
14

2
1
1
3
7
7

10
5
5
14
33
33

17
4

80
20

15
6

71
29
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Objective One

A repeated measures ANOVA was completed to determine if there were significant
differences in distress scores over time for the six participants. The Mauchly’s test of sphericity
indicated the assumption of sphericity had not been violated (Chi-square=5.980, p=0.323).
There was a significant difference noted in distress scores over time (F=8.149, p=0.003).
However, there was not a significant difference found in distress scores with a pairwise
comparison (p=0.323). This can be explained in part due to the small sample size which impacts
the Mauchly’s Test of Sphericity.
The Distress Thermometer (DT) was easy to administer and score. Reliability testing
was completed on the Distress Thermometer (DT) with a Cronbach’s alpha of 0.677. This is
slightly lower than the previously reported internal consistency of 0.86 (Mortez, 2002).
Patients who experienced a moderate to severe level of distress (DT score >4) were
referred to the appropriate clinician based upon the NCCN distress management treatment
algorithm. The majority of patients experienced elevated levels of distress due to physical
problems as a result of their underlying cancer diagnosis or treatment. Physical problems were
assessed and treated by the primary oncology team (advanced practice registered nurses and
oncologists). Data analysis revealed that interdisciplinary referrals (mental health, social work,
and chaplaincy) were limited during this project.
The high prevalence of psychosocial distress seen in this patient population is consistent
with what has been reported in the literature. The Distress Thermometer (DT) facilitated the
timely identification of concerns, thereby enhancing the opportunity for an early intervention. A
high percentage of patients reported an elevated level of distress due to physical concerns at the
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time of their initial psychosocial evaluation. Aggressive symptom management and patient
education, provided by the APRNs, was paramount to decreasing subsequent levels of distress.
Kolcaba’s comfort theory provided an excellent conceptual framework for this evidencebased project. The APRN benefited from developing meaningful relationships, addressing
unmet psychosocial, physical, spiritual and environmental needs, and practicing according to her
own values and patient care philosophy. Participants had their comfort needs met by engaged,
professional, and empathetic nurses who were committed to reducing the level of distress in their
patient population. Finally, the healthcare institution may reap the cultural and financial rewards
for producing the best possible patient and family outcomes.
Objective Two

The findings of this evidence-based practice project were shared with the
interdisciplinary cancer committee. Members of the interdisciplinary cancer committee
reaffirmed their commitment to meeting the physical, emotional, spiritual, and practical needs of
all cancer patients. The committee unanimously agreed to provide full administrative and
clinical support to formally incorporate the NCCN distress management guidelines into routine
oncology care. As a result of this project, a policy for psychosocial distress screening was
written and approved by the cancer committee (see Appendix M). Furthermore, psychosocial
distress screening has been fully integrated into routine oncology care for ambulatory infusion
patients.
All oncology patients receiving care in the ambulatory infusion center are now screened
for psychosocial distress at their initial visit and at least monthly during treatment. Assessments
have been entirely integrated into the electronic health record (see Appendix N).

Patients with

a distress score of >4 are evaluated by the oncology advanced practice registered nurse (APRN)
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and referred to the appropriate clinician for treatment based upon the NCCN treatment algorithm.
Oncology patients with clinical evidence of mild distress (score < 4) are managed by the primary
oncology team.
Limitations, Recommendations, Implications for Change
Limitations

The first limitation of this study was the sample size. It was estimated that 70
participants would enroll in this project. However, due to the limited timeframe to complete this
project, only 21 patients enrolled. The small sample size may have contributed to the lack
statistical difference seen in individual distress scores over time. Furthermore, this project was
conducted in a single institution and there was limited diversity seen within this patient
population. Therefore, the results are not generalizable to other practice settings.
Recommendations

Based upon these findings, all patients with cancer should be screened for distress at their
initial visit and as clinically indicated. Patients with an elevated level of psychosocial distress
should receive a comprehensive treatment plan to address their needs and be referred to the
appropriate clinician for evidence-based treatment.
Implications for Change

Advanced practice registered nurses (APRNs) are in a unique position to make a
difference in screening and managing elevated levels of distress in oncology patients. This
evidence-based project demonstrated that APRNs have a positive impact on improving patient
outcomes. Future research should be aimed at addressing additional nurse-sensitive outcomes
including patient satisfaction, length of hospitalizations, compliance/adherence to treatment, and
collaboration among care givers.
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Summary

Applying evidence to improve patient outcomes is the scientific underpinning for
doctoral-prepared advanced practice nurses. The Doctorate of Nursing Practice (DNP) Capstone
Project should “address a complex practice, process, or systems problem within the student’s
field of expertise, propose an evidence-based intervention to address that problem for a
significant population, and use doctoral-level leadership skills to implement and evaluate the
efficacy of the intervention” (National Organization of Nurse Practitioner Faculties, 2007). This
Capstone Project identified and assessed patients who were experiencing an elevated level of
distress as measured by the NCCN Distress Thermometer. The NCCN clinical practice
guidelines for distress management were utilized to ensure that patients received current,
evidence-based treatment.
In addition to understanding the scientific underpinnings of advanced practice nursing,
doctoral-prepared advanced practice nurses must also utilize nursing theories and values to guide
their decisions and actions. This evidence-based practice project supports the need to develop
meaningful relationships, address unmet psychosocial needs, and practice according to our
philosophy of patient care.
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CINAHL:
Psychologica
l distress,
cancer,
distress
thermomete
r. Funding:
None

Research
Design
and Level
of
Evidence
Level VI

Study
Aim/Purpose
Evaluate
progress in
implementing
distress
management
guidelines by
NCCN member
institutions

Population
Studied/Sample
Size/Criteria/
Power

Methods/Study
Appraisal/
Synthesis
Methods

Primary
Outcome
Measures
and Results

N/A

Electronic survey
to 18 NCCN
institutions;
responses
received from 15.
83% response
rate

8 (53%) of
institutions
screened for
distress.
Reasons for
not screening:
considered
unnecessary;
not enough
resources to
screen or refer
patients.

Author
Conclusions/
Implications
of Key
Findings
Limited
progress on
implementing
distress
management
guidelines. All
institutions did
have mental
health services
available. Only
20% of
member
institutions
screened all
patients for
distress

Strengths/
Limitations
Limited to
NCCN
institutions;
no
community
hospitals.
Survey
methodology;
need to
collect
quantitative
data from
patients.

Comments

Jacobsen, P.,
Donovan, K.,
Trask, P.,
Fleishman, S.,
Zaobra, J., Baker,
F., & Holland, J.
(2005).
Screening for
distress in
ambulatory
cancer patients:
A multicenter
evaluation of the
distress
thermometer.
Cancer (7), 103,
1494-1502.

CINAHL,
Keywords:
screening,
psychologic
distress,
cancer,
distress
thermomete
r. No
funding
source.

Level VI

Determine the
optimal cutoff
score on the
distress
thermometer
(DT) for
identifying
clinically
significant
distress.
Secondary
objective:
Explore
demographic
or clinical
factors
differentiated
patients who
scored above
or below this
cut off score.

380 patients at 5
participating
institutions; all
given a packet of
self-report
questionnaires:
demographic/clini
cal form, DT,
problem list,
HADS, and BSI-18.
Average age 56;
51% male, 49%
female. 85%
White. Average
DT score 3.41.

35
DT 0-10 score;
Problem list with
34 commonly
experienced
problems
grouped into 5
categories.
Clinically
significant
distress on HADS
>15. Clinically
significant
distress on BSI-18:
Males_>10;
females_>13.

Using the
HADS as the
criterion, DT
cutoff score of
4 yielded a
sensitivity of
77% and a
specificity of
68%. Using
the BSI-18 as
the criterion,
DT cutoff
score of 4
yielded a
sensitivity of
70% and a
specificity of
70%. Chisquare
analyses
demonstrated
only
significant
variable was
gender
(women more
likely to have
score >4) and
PS.

Optimal
sensitivity and
specificity was
found utilizing
a cutoff score
of 4

Large sample
size; limited
diversity with
regard to
race,
ethnicity,
education,
and
socioeconomi
c status. No
conclusions
about clinical
benefit to
screening for
distress.

Mitchell, A.
(2010). Short
screening tools
for cancerrelated distress:
A review and
diagnostic
validity meta
analysis. Journal
o f the National
Comprehensive
Cancer Network,
8(A), 487-494.

CIN AHL
Keywords:
psychosocial
distress,
cancer,
distress
thermomete
r.

Level 1

Diagnostic
validity of
tools to
identify
distress in
cancer and
palliative
settings.

Vitek, L.,
Rosenzweig, M.,
& Stollings, S.
(2007). Distress
in patients with
cancer:
Definition,
assessment, and
suggested
interventions.
Clinical Journal
o f Oncology
Nursing 11(3),
413-418.

CINAHL:
Psychosocial
distress,
cancer,
distress
thermomete
r. No
funding
source.

Level VII

Reviewed
nursing role
and
importance of
for screening
for distress

45 potentially
useful short and
ultra-short tools
were identified.

None

36
Systematic search
of
Medline/PubMed,
Embase, SCOPUS
and Web of
Knowledge.
Search limited to
2007-2009.
Focused on
diagnostic validity
studies of tools to
identify distress in
cancer and
palliative care
settings.

Only 3 tools
had diagnostic
accuracy or
validity in
cancer
settings with a
primary focus
on distress:
HADS, Psychol
ogical Distress
Inventory
(PDI), and the
General
Health
Questionnaire
-12 (GHQ-12).

None

None

Most tools are
used to
diagnose
depression and
only a few have
been validated
in a cancer
setting. Best
evidence
supports the
NCCN Distress
Thermometer
(DT)

Supports
routine,
proactive use
of DT in
oncology
patients

Searched only
2 years of
data; didn't
search
CINAHL or
Cochrane
Library.

Good review
of the multiple
screening tools
that have been
used as well as
the history of
visual analog
scales (VAS)

Review only

DT better than
HADS or Beck
Depression
Inventory.
Discusses role
of oncology
nurses

Shimizu, K.,
Ishibashi, Y.,
Umezawa, S.,
Izumi, H.,
Akizuki, N.,
Ogawa, A.,
Fujiwara, Y.,
Ando, M.,
Katsumata, N.,
Tamura, K.,
Kouno, T.,
Shimizu, C.,
Yonemori, K.,
Yunokawa, M., &
Uchitomi, Y.,
(2010).
Feasibility and
usefulness of the
distress
screening
program in
ambulatory care
in clinical
oncology
practice.
PsychoOncology, 19,
718-725.

CINAHL:
Psychosocial
distress,
cancer,
distress
thermomete
r. Funding
source:
Japanese
Ministry of
Health,
Labor, and
Welfare.

Level VI

Development
of distress
screening
program in
ambulatory
care (DISPAC)
program in
Japan

491 patients
completed the
distress and
impact
thermometer
(DIT) during the
DISPAC period.
91.9% completed
the DIT, results
were positive in
37% of patients.

37
Compare the
proportion of
patients referred
to a psycho
oncology service
during the DISPAC
period with the
usual care period

DISPAC
program
useful for
facilitating the
care of
patients with
psychological
distress. Only
25% of
patients
accepted the
referral

5.3% of
patients who
complete the
DIT were
treated by the
psycho
oncology
service
compared to
the usual
number of
patients (0.3%).
P<0.001

Performed at
a single
center.
Comparison
group was not
a control
group. May
have been
some bias
since only
patients on
study were
referred to
psych team.
No
demographic
data. No
data on
patient
impact.

What is the
DIT? Is it
different from
the NCCN DT?
Validity?
Sensitivity?
Specificity?
None of these
were reported

Pasacreta, J.,
Kenefick, A., &
McCorkle, R.
(2008).
Managing
distress in
oncology
patients:
Description of an
innovative
online
educational
program for
nurses. Cancer
Nursing ,31(6),
485-490.

CINAHL,
Keywords:
Psychosocial
distress,
cancer,
distress
thermomete
r. No
funding
source
identified.

Level VI

Describes
online
education
program for
nurses to
screen,
recognize,
manage, refer,
and followup/evaluate
distress in
cancer
patients

Reviewed and
described
participants and
goals of program

Mitchell, A.,
Vahabzadeh, A.,
& Magruder, K.
(2011).
Screening for
distress and
depression in
cancer settings:
Ten lessons from
40 years of
primary-care
research.
Psycho-Oncology
(20), 572-584.

CINAHL,
Keywords:
psychosocial
distress,
cancer,
distress
thermomete
r. No
funding
source
identified.

Level III

Data from
primary care
physicians and
importance of
partnering
with primary
care
physicians to
identify and
treat distress
in oncology
patients

Multiple statistics
on screening
failure and
treatment failure
in primary care.
Identified under
& over detection,
barriers to
identification,
acceptability of
screening,
importance of
trust, frequency
of visits, clinician
confidence/skills,
and training

38
None

None

Must provide
educational
resources &
training for
oncology
nurses in order
to screen and
identify distress
in oncology
patients.

Good review
of how to
overcome
traditional
barriers to
distress
management.

Review the
ICAN program
(joint venture
between NCCN
& APOS). Still
available?
Future
direction:
does nurse
education
make a
difference?

None

None

See population
studied

Narrative

Good review
of historical
data and
barriers as well
as failures
within primary
care to detect
and treat
distress

Spade, C. &
Mulhall, M.
(2010). Teaching
psychosocial
vital signs across
the
undergraduate
nursing
curriculum.
Clinical
Simulating in
Nursing, 6(4),
143-151.

CINAHL;
Keywords:
psychosocial

Level VII

Theoretical
framework,
assessing
patients
holistically,
therapeutic
relationship,
measuring
psychosocial
vital signs

Carlson, L.,
Waller, A.,
Mitchell, A.
(2012).
Screening for
distress and
unmet needs in
patients with
cancer: Review
and
recommendatio
ns. Journal of
Clinical
Oncology,
20(11), 11601177.

CINAHL;
keywords:
psychosocial
distress,
cancer,
distress
thermomete
r. No
funding
sources
identified.

Level V

Literature
review for
psychometric
distress
screening
tools

None; not
validated in
clinical practice

None

39
None

None

Faculty
implications

Not utilized in
clinical
practice; not
validated in
any patient
population.

Incorporates
nursing
therapeutic
relationship;
has ideas
regarding how
to teach
nurses how to
assess for
psychosocial
stress

Authors utilized
Embase, Web of
Knowledge, and
PubMed from
inception to
September 2011;
studies were
excluded if they
were not
validated

30 articles

Important to
include all
stakeholders
and frontline
clinicians when
screening for
distress.

Excellent
review of
distress tools
and needs
assessments
for specific
populations
as well as
general
populations

Discussed
implementatio
n, needs to
screen unmet
needs of
underserved
populations
such as those
with low
income, ethnic
minorities

Fann, J., Ell, K. &
Sharpe, M.
(2012).
Integrating
psychosocial
care into cancer
services. Journal
o f Clinical
Oncology,
30(11), 11781186.

CINAHL;
keywords:
psychosocial
distress,
cancer,
distress
thermomete
r.

Level V

Systematic
identification
of need,
integrated
delivery;
model for
services to
meet
psychosocial
needs

None

Fulcher, C. &
Gosselin-Acomb,
T. (2007).
Distress
assessment:
Practice change
through
guideline
implementation.
Clinical Journal
o f Oncology
Nursing, 11(6),
817-821.

CINAHL.
Keywords:
psychosocial
distress,
cancer,
distress
thermomete
r. No
funding
sources
identified.

Level VI

Pilot study in
radiation
oncology to
implement
NCCN DT

57 Radiation
oncology
patients; total of
157 assessments

40
None

None

Need
evidencedbased
approach on
how to
implement the
psychosocial
guidelines!

Great review
of challenges
and barriers.

How do we
integrate
psychosocial
rounds and
case
management
conferences?
How do we
partner with
PCPs?

Delivered paper &
pencil version of
NCCN DT to
patients at initial
visit and
treatment visits.

Mean baseline
DT score 2.2.
8 patients had
an increase in
distress levels;
11 had a
decrease in
distress levels;
all others
remained the
same.

DT was easy to
use and referral
process was
simplified.
Inconsistent
use of DT by
staff. Not a
burden with
nsg staff; built
into normal
clinical
structure

Small, pilot
study. No
statistical
significance.

Improved
Press Ganey
scores; patient
perception
was positive

Preyde, M., &
Synnott, E.
(2009).
Psychosocial
intervention for
adults with
cancer: A meta
analysis. J ournal
o f EvidenceBased Social
Work, 6, 321347.

CIN AHL
Keywords:
psychosocial
distress. No
funding
source
identified.

Level 1

Psychosocial
interventions
for adults

Search terms:
psychosocial,
care,
intervention,
service, support,
oncology,
effectiveness,
evaluation

41
Articles from
MEDLINE,
CINAHL,
PsycINFO, Social
Sciences Citation
Index, Social
Services
Abstracts,
PubMed
databases from
1999-2007. 27
studies included.

Systematic
review of
psychosocial
interventions
for adults with
cancer

Limited RCT
studies.
Patient
attrition
problematic for
many studies.
Many studies
have clinical
significance.

Limited
studies with
quality
ratings.
Studies had
small sample
sizes. No
statistically
significant
results of
psychological
or
psychosocial
well-being or
adjustment.
Majority of
trials were
breast cancer.
Studies had
poor quality
of reporting
methods and
results.
Articles
dated.

Carlson, L.,
Groff, S.,
Maciejewski, 0.,
& Bultz, B.
(2010).
Screening for
distress in lung
and breast
cancer
outpatients: A
randomized
controlled trial.
Journal of
Clinical
Oncology,
28(33), 48844890.

Fitch, M. (2011).
Screening for
distress: A role
for oncology
nursing. Current
Opinions in
Oncology, 23,
331-337.

Cochrane
Library.
Keywords:
psychosocial
distress,
cancer,
distress
thermomete
r. Funded
by: Alberta
Cancer
Foundation
& Canadian
Cancer
Society

Level II
RCT

Determine
best method
of distress
screening.

588 patients with
breast cancer,
549 patients with
lung cancer.
97.7% power to
detect difference
of 1 point (Cl 95%,
two-tailed test,
standard
deviation 3.0)

MEDLINE:
psychosocial
distress,
cancer. No
funding
source
identified.

Level III

Review of
literature on
screening for
distress and
role of
oncology
nursing

None

42
Patients
randomized to
receive minimal
screening, full
screening, or full
screening plus
phone triage with
referral

Best predictor
o f decreased
anxiety and
depression
were patients
that received
full screening
plus phone
triage and
referral

Routine
screening is
feasible in large
cancer center;
may reduce
future distress
levels,
particularly
when coupled
w ith additional
resources

High
prevalence of
distress in all
groups at
baseline.

None

None

Critical to
identify
distress; many
tools available.

Incorporated
role o f nurses

Kendall, J.,
Glaze, K.,
Oakland, S.,
Hansen, J., &
Parry,C. (2011).
W hat do 1281
distress
screeners tell us
about cancer
patients in a
community
cancer center?

CINHAL:
psychosocial
distress,
cancer,
distress
therm om ete
r. No
funding
sources.

Level VI

Data from
1,281 patients
seen in a
community
cancer center.
Reports
intensity and
frequency of
distress.

Adult Medical and
Radiation
Oncology
patients.
Administered DT

CINHAL:
psychosocial
distress;
cancer
patients. No
funding
sources.

Level VI

268 patients
completed the
DT in
outpatient
oncology
clinic.

Partnership with
off-site local notfor-profit cancer
wellness center to
provide services

PsychoOncology, 20,
594-600.
Smith, J.,
Limesand, D., &
Alikhan, A.
(2011).
Prevalence of
psychosocial
distress in a rural
community
oncology
practice and
impact of
interventions.

Journal of
Clinical
Oncology, 29,
(abstract 9114)

43
Utilized paper
version o f DT.
Patients screened
at initial visit and
subsequent
appts. Radiation
patients screened
weekly.

32% had
distress above
threshold
level. W orry
was most
common
problem
followed by
financial
issues.
Emotional
concerns were
endorsed by
59% o f sample

Distress
screening can
be
accomplished
in a community
cancer center.

Done at St.
Joseph's in
Denver

Outpatient
oncology clinic

Mean distress
level 4.18.
46% scored
above the
threshold (5 in
this study).
Only 10%
accepted
interventions
at an off-site
wellness
center.

Prevalence of
psychosocial
distress higher
in rural
population
than
urban/academi
c outpatient
clinics. Need to
expand on-site
cancer specific
support groups.

Abstract at
2011ASCO
Meeting

Lowery, A., &
Holland, J.
(2011).
Screening cancer
patients for
distress:
Guidelines for
routine
implementation.

Community
Oncology, 8(11),
502-505.

MEDLINE:
psychosocial
distress;
cancer. No
funding
sources.

Level V

Reviewed
history of
guidelines and
routine
screening as
standard of
care

Review of
literature

NCCN DT is a
rapid screening
tool; easy to
implement.
Incorporate as
standard of
care into
practice.

Mitchell, A.,
Lord, K., Slattery,
J., Grainger, L, &
Symonds, P.
(2012). How
feasible is
implementation
o f distress
screening by
cancer clinicians
in routine clinical
care? Cancer,
March 2012.

MEDLINE:
psychosocial
distress,
cancer. No
funding
source.

Clinicians
asked to
record their
feedback after
implementatio
n o f a distress
screening
program

50 clinicians and
379 patients in a
large academic
hospital in the UK

45
Used the
Emotional
Thermometer
(ET)

Clinicians
believed
screening was
useful in 43% of
assessments.
Assisted staff in
changing the ir
clinical opinion
about perceived
distress levels.
37.5% clinicians
fe lt that
screening was
impractical fo r
routine use. 3
variables
associated w ith
high staff
satisfaction:
prior training,
talking to
patient about
psychosocial
issues, and
improved
detection of
psychological
problems.

33% of
clinicians
considered
screening not
useful/practical
. >50%
believed
screening
helped with
communication
and recognition
o f distress.

Reviewed
clinician and
patient
perspectives

Absolom, K.,
Holch, P., Pini, S.,
Hill, K., Liu, A.,
Sharpe, M.,
Richardson, A., &
Velikova, G.
(2011). The
detection and
management of
emotional
distress in
cancer patients:
The views of
health-care
professionals.

PsychoOncology, 20,
601-608.

Psychlnfo:
psychosocial
distress.
Funded by
NCRI
Supportive
and
Palliative
Care
Research
Collaborativ
e Grant,
University of
Leeds

Explore the
views o f
cancer
professionals
regarding their
current roles
and
responsibilities
in the
detection and
management
o f emotional
distress, use of
screening
tools, and
access to
resources.

Interviews with
23 professionals
(6 CNS, 8
oncologists, 4
surgeons, 5 ward
sisters) from
hospitals in the
UK.

46
Semi-structured
interview
schedule.
Interview data
analyzed using
framework
analysis to
identify common
themes.

Described how
cancer
professionals
perceive their
role and
responsibilitie
s in the
detection and
management
of emotional
distress.
Attitudes
towards the
use of
validated
screening
tools for
detecting
emotional
distress.
Access to
specialist
supportive
services.
Views o f what
currently
limits the
management
of emotional
distress.

All professionals
acknowledged
im portance of
detecting
em otional distress
in th e ir patients.
The CNSs w ere
heavily relied upon
to assess patients,
provide em otional
support, and refer
to specialist
services.
Oncologists and
surgeons did not
consider em otional
distress to be a key
part o f th e ir role.
M ain barrier was
lack o f guidance on
referral pathways
to help s ta ff decide
when it was
appropriate to
refer, to w hich
service, and h o w to
access th e services.

Study sample
small; drawn
from one
geographic
location in
the UK.

Excellent study
to support
utilization of
NCCN
guidelines. All
staff needed
additional
training on
distress
assessment
and
management.
Need for
standardized
screening
tools.

Dudgeon, D.,
King, S., Howell,
D., Green, E.,
Gibert, J.,
Hughes, E.,
Lalonde, B.,
Angus, H., &
Sawka, C. (2012).
Cancer care
Ontario's
experience with
implementation
o f routine
physical and
psychological
symptom
distress
screening.

PsychoOncology, 21,
357-364.

PsycINFO:
psychosocial
distress,
cancer. No
funding
source
identified.

Ql initiative to
implement
routine
distress
screening with
ESAS for
cancer
patients seen
in 14 Regional
Cancer
Centers

Screening
increased from
3.5% to 47%.
Palliative care
clinics screened
70 to 90% of
patients. 85% o f
respondents felt
it was
worthwhile. 44
individuals
participated in 14
interviews and 7
focus groups.

47
Used Edmonton
Symptom
Assessment
System (ESAS)
w ith a Calgary
problem checklist
as part o f the
recommended
minimum
standard for
distress screening
fo r patients in
Canada.

Allow centers to
examine the
roles of
different
members of the
health care
team;
reorganize w ork
flo w and
responsibilities.
Increase in
educational
activities fo r
staff. Staff liked
objective
assessment.
Algorithms and
guides were
developed to
support furthe r
assessment and
interventions.
Demonstrated
com m itm ent to
patientcentered care.

Routine
screening is
possible and
creates a
culture that is
more patientcentered.

Canadian
study;
different
distress tool

Currently
evaluating
feasibility of
telephone
survey.

Skrutkowski, M.,
Saucier, A.,
Eades, M.,
Swidzinski, M.,
Ritchie, J.,
Marchionni, C.,
& Ladouceur, M.
(2008). Impact
o f a pivot nurse
in oncology on
patients with
lung or breast
cancer:
Symptom
distress, fatigue,
quality o f life,
and use of
healthcare
resources.

CINAHL:
psychosocial
distress,
cancer. No
funding
source
identified.

Level II

RCT; patients
randomized
assigned to an
intervention
group w ith a
pivot nurse
and usual care
by clinic
nurses or to a
control group
w ith usual
care only.

3 outpatient
ambulatory
oncology clinics in
Quebec, Canada.
113 patients with
lung cancer and
77 patients with
breast cancer.
Participants
completed
Symptoms
Distress Scale as
well as brief
fatigue inventory
and functional
assessment of
cancer therapy
scale. Variables:
symptom distress,
fatigue level, QOL,
healthcare usage.

CINHAL:
psychosocial
distress,
cancer. No
funding
source
identified.

Level V

Overview of
incidence,
diagnosis, and
treatm ent of
emotional
distress in
patients with
cancer

N/A

Oncology
Nursing Forum,
35(6), 948-954.

Madden, J.
(2006). The
problem of
distress in
patients with
cancer: More
effective
assessment.

Clinical Journal
of Oncology
Nursing, 10(5),
615-619.

48
PNO reviewed
diagnosis,
expected side
effects and
available
resources with
patients. Also
assessed patients'
needs and coping
skills.
Coordinated care
across treatm ent
modalities. Usual
care consisted of
symptom
assessment and
teaching but was
not formally
organized.

No significant
difference in
symptoms
distress,
fatigue, QOL,
or healthcare
usage.
Statistically
significant
difference in
distress over
tim e based on
cancer type;
lung cancer
group
exhibited
more distress
than those in
the breast
cancer group
p=0.023

Experienced
nurses were
able to offer as
much care as
PNO.
Ambulatory
nurses were
oncology
certified; PNOs
did not have
any oncology
background
and were not
certified.

Small sample
size (target
was 400).

Distress is
common!
Oncology
nurses can
become
proficient at
use o f distress
thermometer.

Limited
statistics

Pivot Nurse is
sim ilarto
nurse
navigator role
in USA

Grassi, L. (2011).
Educational
intervention in
cancer
outpatient clinics
on routine
screening for
emotional
distress: An
observational
study. Psycho-

MEDLINE:
psychosocial
distress,
cancer,
distress
therm om ete
r. No
funding
source
identified.

Level VI

Examine the
effect o f an
educational
model on
distress
screening in
newly
diagnosed
cancer
patients
referred to a
PsychoOncology
Service (POS).

Distress and
problems among
newly diagnosed
cancer patients
who were
referred based
upon clinician
judgm ent and
after an
education
intervention on
the DT.

MEDLINE:
distress
therm om ete
r. No
funding
source
identified.

Level VI

Social worker
pilot program
to implement
DT in head &
neck cancer
population

763 patients
screened; 19.6%
had overall DT >4
or higher. Most
frequently
identified physical
problems:
fatigue, sleep,
eating difficulties.
Emotional
problems: worry,
nervousness,
depression.

Oncology, 20(6),
669-674.

Frost, G., Zevon,
M., Gruber, M.,
Scrivani, R.
(2011). Use of
distress
therm om eter in
an outpatient
oncology setting.

Heath & Social
Work, 36(4),
293-297.

49
Study 1:
Physicians &
nurses referred
newly diagnosed
patients by using
their own
judgm ent based
on their
experience with
fatigue. Study 2:
Educational
intervention was
developed.
Patients w ith DT
score >4 were
referred to POS.

Implementatio
n o f the DT
determined a
higher and
more accurate
referral of
patients.
Acceptance of
DT by staff
was low.

1/3 o f patients
referred based
solely on
clinician
judgm ent did
not show
elevated levels
o f distress. Use
o f DT resulted
in 79% increase
in the accuracy
o f patients
needing a
referral.

Observational
study; difficult
to generalize

Pilot program

NCCN DT
implementatio
n fo r all head
& neck cancer
patients

Distress scores
pre and post
intervention
were not
measured.

Conducted in
single
institution;
may lim it
generalizabilit

y

Hammonds, L
(2012).
Implementing a
distress
screening
instrument in a
university breast
cancer clinic: A
quality
improvement
project. Clinical

Journal of
Oncology
Nursing, 16, (5),
491-494.

MEDLINE:
distress
therm om ete
r. No
funding
source
identified.

Level VI

Pilot project
done in an
academic
setting

104 patients
consented to
participate. 55
patients were
identified as
having elevated
level o f distress
(DT >4). 11
patients were
referred for
support.

50
Pilot study

DT increased
nurse
identification
o f distress and
referrals for
support.

Nurses are
positioned to
identify distress
among patients
and make
referrals for
support. NCCN
DT is an
effective tool
that can be
used by nurses
in busy
settings.

Small sample
in one
institution.
No
measurement
o f distress pre
and post
intervention.

Hurria, A., Li, D.,
Hansen, K., Patil,
S., Gupta, R.,
Nelson, C.,
Lichtman, S.,
Tew, W., Hamlin,
P., Zuckerman,
E., Gardes, J.,
Limaye, S.,
Lachs, M., &
Kelly, E. (2009).
Distress in older
patients with
cancer. Journal

of Clinical
Oncology,
27(26), 43464351.

MEDLINE:
distress
therm om ete
r. Funding
source: Paul
Beeson
Career
Developmen
t Award in
Aging
Research &
American
Society of
Clinical
Oncology
Association
o f Specialty
Professors
Junior
Developmen
t Award in
Geriatric
Oncology.

Level VI

Determine the
prevalence of
distress in older
adults with
cancer utilizing
the DT.
Determine
whether
predictors of
distress could
be identified
using a brief
geriatric
assessment that
captured
information
about the
individual's
functional
status,
comorbid
medical
conditions,
psychological
state, social
support, and
nutritional
status.

Patients >65 in
large academic
setting. Patients
completed the
geriatric
assessment prior
to the appt. 245
patients
completed the
geriatric
assessment. Of
these, 214
patients also
completed the
DT.

51
Geriatric
Assessment & DT
were utilized. All
tum or types.

Mean DT score
was 3; mean
was 2. 41% of
patients had a
score of 4 or
greater.
Variables
associated w ith
higher levels of
distress:
needing
assistance w ith
ADLs (Pc.OOOl);
Karnofsky <70
(P=.001); having
3 or more
comorbid
conditions
(P=.047), poor
eyesight
(P=.002),
requiring
services at
home (P=0.52),
and needing
assistance to
compete the
geriatric
assessment
(P=.0Q3).

DT and geriatric
assessment
were used to
explore
relationship
between
distress and
several
variables that
predict
m orbidity and
m ortality in
older adults.
Helped to
pinpoint the
unique causes
of distress that
face older
adults with
cancer.

Convenience
sample;
primarily
females with
breast cancer.
Limits
generalizabilit
y. Did not
discuss how
chemotherap
y could make
DT score
higher or
lower. Data
was selfreported.

Mertz, B.,
Bistrup, P.,
Johansen, C.,
Dalton, S.,
Deltour, 1.,
Kehlet, H., &
Kroman, N.
(2012).
Psychological
distress among
women with
newly diagnosed
breast cancer.

MEDLINE:
psychosocial
distress,
cancer. No
funding
source
identified.

Level VI

Determine
prevalence of
distress and
investigate the
related
problems and
characteristics
o f women
w ith breast
cancer who
experienced
psychological
distress at the
tim e of
diagnosis.

Women with
newly diagnosed
breast cancer
prior to breast
surgery. 426
invited; 357
responded. 343
patients
completed the DT
and DT problem
list.

CINAHL:
psychosocial
assessment,
cancer. No
funding
sources
identified.

Level VII

Review of
standards,
guidelines,
and quality
measurement

None

European
Journal of
Oncology
Nursing, 16(A),
439-443.

Jacobsen, P. &
Wagner, L
(2012). A n ew
quality standard:
The integration
o f psychosocial
care into routine
cancer care.
Journal of

Clinical
Oncology, 30,16.

52
Cross-sectional
data from a
questionnaire.

None

77% of
women had a
score >3; 43%
scored >7.
Mean distress
score 5.4.
Most frequent
problems:
worry &
nervousness.
Younger
women (<50)
had higher
distress scores
than older
women (>50).
No significant
association
between
distress and
social support.

12% accepted a
referral to
psychological
support, 54%
asked for
possible future
referral, 30%
refused
referral.

Study done 12 days prior
to surgery;
may have
resulted in
increased
number of
women
experiencing
w orry about
the surgery.
Many physical
symptoms
generally
related to
chemotherap
y (fatigue,
mouth sores)
were
reported prior
to surgery.

None

Overview of
accomplishmen
ts in standards
of care, clinical
practice
guidelines and
development of
measurable
indicators of
quality

No review of
patient
outcomes

Were these
results
expected preoperatively?

Snowden, A.,
White, C.,
Christie, Z.,
Murray, E.,
McGowan, C., &
Scott, R. (2011).
The clinical
u tility o f the
distress
therm om eter: A
review. British

Medline:
Psychosocial
distress,
distress
therm om ete
r. No
funding
sources
identified.

Level 1

Meta-analysis
review to
ascertain use
o f DT in
clinical
practice

Searched
Medline, CINAHL,
PsycINFO,
Embase, ASSIA,
British Nursing
Index, AMED,
CCTR and HMIC.

Prevalence
and associated
symptoms of
distress in
newly
diagnosed
lung cancer
patients

98 consecutive
patients with
newly diagnosed
NSCLC or SCLC
asked to
completed the DT
and ESAS as their
first visit post
diagnosis and
prior to any
treatm ent. Mean
age 63, M/F ratio
54:44. 81'% of
patients had PS of
0-1.

Journal of
Nursing, 20(4),
220-227.

Steinberg, T.,
Roseman, M.,
Kasymjanova, G.,
Dobson, S.,
Lajeunesse, L,
Dajczman, E.,
Kreisman, H.,
MacDonald, N.,
Agulnik, J.,
Cohen, V.,
Rosberger, Z.,
Chasen, M., &
Small, D. (2009).
Prevalence of
emotional
distress in newly
diagnosed lung
cancer patients.

Support Care
Cancer, 17,
1493-1497.

Psychlnfo:
psychosocial
distress,
cancer.
Funded by
an
unrestricted
grant from
SanofiAventis.

Level IV

53
Identified 40
stories that
examined the
function o f the DT
alone, together
w ith the problem
list, and other
validated
measures.

DT score o f 4
is appropriate
fo r distress
screening;
additional
studies in
oncology
practice
needed.

Limited studies
available to
review

ESAS is a
numerical rating
scale that
assesses 9
physical and
psychosocial
symptoms
common in
cancer patients.
DT cut o ff score
was 4.

Level of
distress not
associated
w ith age, sex,
weight loss, or
performance
status. 51% of
patients were
identified as
distressed by
the DT at the
tim e of
diagnosis.
Mean level of
distress
assessed by
the DT was
3.64.
Depression
and
nervousness
were
significant
predictors of
elevated
distress score.

Prevalence of
distress in lung
cancer patients
is high. Single
item DT is
extremely
useful
instrument to
rapidly identify
elevated levels
o f distress.

Excellent
review o f
literature;
correlates
closely to the
Capstone
project.
Limited to
lung cancer
patients. Did
not measure
the impact of
any
interventions.

Keir, S., CalhounEagan, R.,
Swartz, J., Saleh,
0., & Friedman,
H. (2008).
Screening for
distress in
patients with
brain cancer
using the NCCN's
rapid screening
measure.

PsycINFO:
Psychosocial
distress,
cancer,
distress
therm om ete
r. No
funding
source
identified.

Level IV

Evaluated the
extent and
sources of
distress in
patients with
brain cancer

CINAHL:
Psychosocial
distress,
cancer. No
funding
sources
identified.

Level VII

Overview of
assessment
and
management
o f distress as
well as
common
psychiatric
disorders
experienced
by oncology
patients.

75 patients
diagnosed w ith a
primary brain
cancer. Inclusion
criteria: at least
age 18, ability to
speak, read, and
w rite English,
Karnofsky score
>70

PsychoOncology, 17,
621-625.
Holland, J., &
Alici, Y. (2010).
Management of
distress in
cancer patients.
Journal of

Supportive
Oncology,8(1), 412.

None

54
Participants asked
to complete
w ritten DT

52% of
patients had a
DT score > 4.

None

None

Interventions
should be
designed to
address worry,
sadness, and
depression
seen in brain
cancer
patients.

Did not study
any
interventions

Nice review of
psychiatric
disorders.
Important to
screen and
identify
patients at risk.
Need further
research to
improve
assessment and
treatm ent of
distress;
especially
among
underserved
population.

55
Jacobsen, P.,
Holland, J.,
Steensma, D.
(2012). Caring
for the whole
patient: The
science of
psychosocial
care. Journal of

CINAHL:
psychosocial
distress,
cancer. No
funding
source
identified.

Level VII

Summary of
recent science;
importance of
screening and
referral per
the NCCN
Guidelines.

None

None

None

Promotes
greater
knowledge and
understanding
o f psychosocial
care

CINAHL:
Psychosocial
distress,
cancer. No
funding
source
identified.

Level VII

Need for
adopting the
NCCN
guidelines

None

None

None

Recognizes
need fo r RCTs

CINAHL:
Psychosocial
distress,
cancer. No
funding
source
identified.

Level VII

Barriers to
implementing
the NCCN
Guidelines.

None

None

None

Emphasizes
need to identify
patients, link
them to
appropriate
resources,
coordinate
care, and
follow up on
care delivery

Introduction
fo r special
oncology
issue
dedicated
solely to
distress
screening

Clinical
Oncology,
30(12), 1-3.
Jacobsen, P.
(2007).
Screening for
psychological
distress in
cancer patients:
Challenges and
opportunities.
Journal of

Clinical
Oncology,
25(29), 4526
4527.
Pincus, H. &
Patel, S. (2009).
Barriers to the
delivery of
psychosocial
care for cancer
patients:
Bridging mind
and body.

Journal of
Clinical
Oncology, 27(5),
661-662.

None

Kadan-Lottick,
N„
Vanderwerker,
L., Block, S.,
Zhang, B., &
Prigerson, H.
(2005).
Psychiatric
disorders and
mental health
service use in
patients with
advanced
cancer. Cancer,
104, 2872-2881.

Medline:
psychosocial
distress,
cancer.
Funded by
the National
Institute of
Mental
Health.

Level VI

Determine the
prevalence of
diagnosable
psychiatric
illness and
describe the
mental health
services
received and
predictors of
service
utilization in
patients with
advanced
cancer.

251 patients with
advanced cancer.
Eligible patients:
distant mets,
primary therapy
failure, nonpaid
caregiver, age
>20, English or
Spanish speaking,
adequate
cognitive ability.

56
Trained
interviewers
administered the
DSM-IV modules
fo r MDD, GAD,
panic disorder,
PTSD, and
questionnaire
regarding mental
health service
utilization.

12% patients
met criteria fo r
major
psychiatric
condition; 28%
had access a
mental health
intervention fo r
psych diagnosis
since the cancer
diagnosis. 17%
had talked to a
mental health
professional;
90% willing to
receive
treatm ent fo r
emotional
problems.
Mental health
services were
not accessed by
55% o f patients
w ith major
psychiatric
conditions.

Advanced cancer
patients
experience major
psych disorders
at a prevalence
similar to general
population but
affected
individuals have
a low rate of
utilizing mental
health services.
Oncology
providers should
discuss mental
health concerns
w ith their
patients.

Only 63%
participation
rate; potential
for bias.

Mitchell, A.,
Chan, M., Bhatti,
H., Halton, M.,
Grassi, L.,
Johansen, C., &
Meader, N.
(2011).
Prevalence of
depression,
anxiety, and
adjustment
disorder in
oncological,
haematological,
and palliative
care settings: A
meta-analysis of
94 interviewbased studies.

Lancet Oncology,
1 2 , 160-174.

Medline:
Psychosocial
distress,
cancer. No
funding
source
identified.

Level 1

Quantitative
summary of
the prevalence
o f depression,
anxiety, and
adjustment
disorders.

Searched
Medline,
PsycINFO,
Embase, and Web
o f Knowledge
sites fo r studies
that examined
depression,
anxiety, and
adjustment
disorders in
adults with
cancer. Studies
restricted to
those using psych
interviews.

57
24 studies with
4007 patients
were identified.
Included 7
countries.

16.5 % rate o f
depression,
15.4% rate of
adjustment
disorder, 9.8%
rate of
anxiety. No
consistent
correlates of
depression; no
effect o f age,
sex, clinical
setting, cancer
type or
duration.

Depression and
anxiety is less
common in
cancer patients
than previously
reported.

Not a
longitudinal
study. Did
not examine
stage of
disease or
duration of
treatm ent.
Only used
interviewbased studies

Swanson, J. &
Koch, L. (2010).
The role o f the
oncology nurse
navigator in
distress
management of
adult inpatients
w ith cancer: A
retrospective
study. Oncology

Nursing Forum,
37(1), 69-76.

Medline:
Psychosocial
distress,
cancer.
Funded by
the National
Cancer
Institute.

Level VI

To determine
if an ONN role
as an
intervention
decreases the
distress of
adult
inpatients with
cancer.

Retrospective
chart review,
convenience
sample o f 55
inpatients.

58
Nurses asked
patients with
cancer to rate
their distress daily
during their stays.
Correlation
studies and twotailed t tests used
to examine the
relationship
between the
change in distress
and the ONN
intervention.

Patients seen
by ONN had
lower distress
scores on
dismissal
(p=. 1046).
Statistically
significant
effect for
patients <65
years (p=.044)
and for
patients who
live in a rural
setting
(p=.045).

ONN can lower
cancer-related
distress scores,
increase
patient
satisfaction?
Increase QOL?

Retrospective
chart audit;
involved
inpatients
only.

Vodermaier, A.,
Linden, W., &
Siu, C. (2009).
Screening for
emotional
distress in
cancer patients:
A systematic
review of
assessment
instruments.

Journal of the
National Cancer
Institute,
101(21), 1464-

CINAHL:
Psychosocial
distress,
cancer,
distress
therm om ete
r. Funded
by the
Canadian
Institutes for
Health
Research.

Level 1

Examined the
psychometric
properties of
existing tools
used to screen
patients for
emotional
distress.

Systematic search
o f Medline and
PsycINFO
databases.
Keywords:
depression,
anxiety,
screening,
validation, and
scale. Validation
criteria: # o f
validation studies,
# o f participants,
generalizability,
reliability, quality
o f criterion
measure,
sensitivity, and
specificity.

CINAHL:
psychosocial
distress,
cancer. No
funding
sources
identified.

Level 1

Literature
review on
depression in
people with
cancer:
occurrence,
assessment &
treatm ent.

Systematic search
PubMed,
PsycINFO,
CINAHL, and
Biosis. Terms:
neoplasms,
depression,
depressive
disorder,
antidepressant
agents

1488.

Pirl, W. (2004).
Evidence report
on the
occurrence,
assessment, and
treatm ent of
depression in
cancer patients.

Journal of the
National Cancer
Institute, 32-39.

59
Yielded 106
validation studies
that described 33
screening
measures

Ultra short
measures did
best in
palliative care
settings; best
short
measures
were ESDS &
HADS, best
long measures
GHQ. 15
studies
utilized the DT
for a total of
4,088
participants. +
Generalizabilit
y; moderate
reliability,
moderate
criterion
measures,
moderate
validity, Fair
judgment.

Several generic
and newly
develop
specific
instruments
met the highquality criteria
fo r use in
emotional
distress
screening of
cancer
patients. Best
to use the
shortest tool
that is easiest
fo r clinician to
interpret.

Reviewed a
large number
o f tools;
unable to
judge the
predictive
validity of
tools. Need
more
information
on how
screening
affects long
term
outcomes and
QOL

350 studies
identified; limited
by English
language
published
between 1966
and 2001.

M ajority of
studies are
cross-sectional
prevalence
studies.
Prevalence
rates vary
widely; data
suggests
approx. 1025% o f cancer
patients suffer
from MDD.

DSM Manual
Criteria for
MDD is the
standard
assessment
tool

No RCTs or
alternative
med studies.
Need
longitudinal
studies to
estimate the
incidence of
depression
before cancer
dx

Roth, A.,
Kornblith, A.,
Batel-Cooper, L.,
Peabody, E.,
Scher, H., &
Holland, J.
(1998). Rapid
screening for
psychologic
distress in men
w ith prostate
cancer: A pilot
study. Cancer,
82(10), 19041908.

CINAHL:
distress
therm om ete
r.
Supported
by grants
from
PepsiCo
Foundation
and the T.J.
Martell
Foundation.

Level VI

Use rapid
measure tool
to identify
patients with
distress;
compared
HADS w ith DT

Median age 71,
diagnosed a
median o f 4 yrs.
DT cut o ff score 5;
28.6% score at or
above this score.

60
121 consecutive
men with
prostate cancer
asked to
complete the
HADS and the DT

Patients with
score >5 on DT
or >15 on
HADS were
referred to
psych MD for
assessment;
31% of
patients were
evaluated by
MD. Good
correlation
between
elevated DT
scores and
presence of
distress as
measured by
DSM criteria

Rapid screening
approach was
acceptable to
patients and
clinicians

No data on
pre and post
intervention

O'Sullivan, C.,
Bowles, K., Jeon,
S., Ercolano, E.,
McCorkle, R.
(2011).
Psychological
distress during
ovarian cancer
treatm ent:
Improving
quality by
examining
patient problems
and advanced
practice nursing
interventions.

Nursing
Research and
Practice, 1-14.

CINAHL:
psychosocial
distress,
cancer,
distress
therm om ete
r. Funded
by a grant
through the
NIH.

Single blind
prospective
RCT, designed
to test the
hypothesis
that women
with
suspected
ovarian cancer
who received
a specialized
nursing
intervention
program
would have
greater
improvement
in QOL
measures over
tim e than
women in an
attentioncontrol group.

145 subjects
randomized
following surgery
All screened for
DT at baseline
and prior to
hospital
discharge. DT
cut-off score was
4.

61
Secondary
analysis of
research records
from a 6 month
RCT included 32
women with
primary ovarian
cancer. All 18
received APN
visits over 6
months.
Demographic,
clinical factors,
patient problems
and APN
interventions
obtained through
content analysis
and categorized
via the Omaha
system.

Clinically
significant psych
conditions were
identified in
44% of
participants
who had
elevated DT
scores; they
agreed to psych
referral. High
distress subjects
who refused
mental health
intervention
had more
income and
housing
problems than
the other
subjects,
received the
fewest
interventions at
baseline and
received
progressively
more
interventions
throughout the
study.

Highly
distressed
women not
psychologically
ready to work
through
emotional
consequences
o f cancer at
treatm ent
onset may
obtain support
from APNs to
manage cancer
problems as
they arise.

Retrospective
chart audit,
ovarian
cancer
population
only. Sample
lacked
diversity.

Appendix B: Logic Model

Project:
Im p le m e n ta tio n o f NCCN Distress Therm om eter (DT)

Problem Ide ntificatio n:

-O ncolo gy Patients
-NCCN D T T o o l
-NCCN A lgorithm
Infusion Staff
-Chaplains
-Dieticians
-Psychotherapists
-Social W orkers (SW )
-Physicians
-Com puter/ D atabase

-A ssessm en t tim e
-Staff education
-Space for privacy
-Co nsult schedule
-Staff com m unication
-Tim efram e
-P atien t privacy
-Fam ily concerns
-Cultural concerns

•

D ifficu lty making tre a tm e n t decisions

•

Poor com pliance to tre a tm e n t

•

Extra visits t o medical providers

•

Poor satisfaction w ith ca re

•

Poor q u a lity o f life

-Adm inister NCCN DT
assessm ent
-M edications
-Lab Testing
-Case M gr. Referrals
-Hospice Referrals
-D ietary Consults
-SW Consults
-Psych Referrals
-Transportation requests
-Pain M gm t. Referrals
-PT/O T Referrals
-Lym phedem a Referrals
-Support G roups
-M eals on W heels

-70 Participants
-Baseline DT score
-Consultations
-M on th ly Assessm ents
-Changes in DT scores
-Fam ily/caregiver
sup po rt
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Appendix C: Project Timeline

1 /1 4 /2 0 1 3

2 /1 9 /2 0 1 3

5 /1 9 /2 0 1 3

R e cru itm e n t begins

R e cruitm en t Ends
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Appendix D

February 2013
Dear Participant:
My name is Denise Sartz. I am a student at Regis University in the Doctorate of Nursing
Program under the supervision of Dr. Diane Ernst. You are invited to participate in an evidencebased project entitled: Screening for Distress in Ambulatory Oncology Patients: The COPE
Project. You have been asked to be a part of this project because you have been diagnosed with
cancer and you are receiving treatment at Cheyenne Regional Medical Center. The purpose of
this project is to identify new programs and services that will improve care for oncology patients
receiving their treatment at Cheyenne Regional Medical Center. This project has been approved
by Regis University’s Institutional Review Board as well as Cheyenne Regional Medical Center.
If you agree to participate in this project, I will ask you to complete a written checklist called a
“distress thermometer” at least monthly during one of your visits to the ambulatory infusion
center at Cheyenne Regional Medical Center. The checklist will take approximately 5 minutes
to complete. You will also meet with an advanced practice nurse at each visit to review the
results of the checklist. If you are experiencing distress during any part o f your treatment, you
will be offered additional care and support which may include: a chaplain, dietician, financial
counselor, mental health professional, or other specialist. Your participation will last
approximately 3 months. If you need help with distress after the project has been completed you
will continue to receive treatment and support.
Your participation in this project is confidential. None of the information will identify you by
name. All records will be stored in a locked cabinet which can be only be accessed by me or a
co-investigator. The results of this project may be presented at meetings or in publications;
however, your identity will never be disclosed in those presentations or publications.
There are no direct costs to you for participating in this project. You or your insurance company
will be charged for any medical care and/or hospitalizations related to your cancer treatment.
You will not be paid for taking part in this project.
Please take your time making a decision and feel free to discuss it with your family and friends.
If you have additional questions or concerns please contact me at: 307-633-6875 or 307-274
7827. You can also reach me via email at: denise.sartz@crmcwy.org. You can also contact my
project advisor, Dr. Diane Ernst, at 303-964-5768 any time during this project.
Sincerely,

Denise A. Sartz, MS, AOCNP, FNP-C
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Appendix E

December 12, 2012
Denise Sartz
Cheyenne Regional Med Ctr
214 E. 23rd St
Cheyenne, Wyoming 82001
On behalf of the National Comprehensive Cancer Network® (NCCN®), I am writing to grant you
permission to reproduce the Distress Thermometer Screening Tool Figure (DIS-A) from the NCCN
Clinical Practice Guidelines in O ncology (NCCN Guidelines®) fo r Distress Management V.2.2013 as
described in your original request for use with your patients. Permission is granted solely for the
purposes described herein, which you represent and warrant to be for non-promotional educational use
only. The following qualifications also apply to the permission granted by this letter:
1. You agree to include a citation giving full credit to the NCCN Guidelines® as follows:
Reproduced with permission from the NCCN Clinical Practice G uidelines in O ncology (NCCN
Guidelines®) fo r Distress Management (V.2.2013). © 2012 National Comprehensive Cancer Network,
Inc. Available at: NCCN.org. Accessed [Month and Day, Year]. To view the most recent and complete
version of the NCCN Guidelines®, go on-line to NCCN.org.
2. Permission is granted solely for the purposes described within your original request and expires after
one year. An extension on your permission request may be requested at that time.

3. You agree that you will not translate, change, adapt, delete, extract portions, or modify the content of
the NCCN Guidelines® fo r Distress Management, unless explicit permission is provided above.

4. Permission is for reproduction of the NCCN Guidelines in print media only. No Electronic Rights
(including CD-ROM and Internet) are granted. Reproduction of the NCCN Guidelines into any other
medium, including but not limited to electronic media, is explicitly prohibited. You further agree that any
reproduction of the NCCN Guidelines will include NCCN’s URL address www.nccn.org, to link to the most
updated version of the NCCN Guidelines fo r Distress Management.

5. Permission is granted for reproduction in the English language only.

6. You acknowledge that the NCCN is sole owner of the NCCN Guidelines, and any derivative works
created from the guidelines. You further acknowledge that National Comprehensive Cancer Network®,
NCCN®, NCCN Guidelines®, NCCN Compendium®, NCCN Templates®, GUS™, NCCN Flash Updates™,
NCCN Trends™ Surveys & Data, and NCCN Oncology Insights Reports™ are trademarks owned by the
National Comprehensive Cancer Network, Inc. You agree that you shall not use the Marks in any manner
or for any purpose other than to acknowledge ownership of the NCCN Guidelines as described in this
letter. Your use of the Marks and/or Guidelines for the purposes described herein in no way constitutes
an endorsement of your works or opinions by the NCCN. You acknowledge that use of the Marks and
reprinting of the Guidelines pursuant to the permission granted hereunder shall not create in your favor
any right, title, or interest in or to the Marks and/or the Guidelines. The permission granted hereunder is
for a one-time use of the Marks and/or Guidelines. You agree that each use of the Marks and/or the
Guidelines by you, beyond or in addition to that described herein, shall require written approval by the
NCCN.
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7. Your use of the Marks and/or Guidelines as described herein shall signify your acceptance of the terms
and conditions of this letter. The NCCN reserves the right to at any time revoke the permission granted
hereunder if, in its discretion, the NCCN determines that you have violated or are in violation of the terms
of this letter of permission.

Thank you for your interest in the work of the NCCN.
Sincerely,

John A nao
John T. Arnao
Business Development Coordinator
National Comprehensive Cancer Network

Additional Information on the NCCN Guidelines:
The NCCN Guidelines® - the recognized standard for clinical policy in oncology - are the most comprehensive and most frequently
updated clinical practice guidelines available in any area of medicine. Covering 97 percent of all patients with cancer and updated
on a continual basis, the NCCN Guidelines are developed through an explicit review of the evidence integrated with expert medical
judgment and recommendations by multidisciplinary panels from NCCN Member Institutions. There are 44 individual panels,
comprising nearly 900 clinicians and oncology researchers from the 21 NCCN Member Institutions and their affiliates. Specific
treatment recommendations are implemented through performance measurement. NCCN Guidelines Panels address cancer
detection, prevention and risk reduction, workup and diagnosis, treatment, and supportive care.
NCCN Guidelines have become the most widely used guidelines in oncology practice and have been requested by cancer care
professionals in more than 115 countries. There has also been substantial international interest in translating the NCCN Guidelines
into a variety of languages. Select NCCN Guidelines have been translated into Chinese, German, Italian, Japanese, Korean, Polish,
Portuguese, Russian, Spanish, and Turkish.
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Summary of the Guidelines Updates

Key Terms:
• Distress (DIS-1)
• Definition of Distress in Cancer (DIS-2)
• Standards of Care for Distress Management fDIS-3)
Overview of Evaluation and Treatment Process (DIS-4’)
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Clin ical Trials: T h e NCCN
b e lie ve s th a t th e b e st m a n a g e m e n t
fo r a n y c a n c e r p a tie n t is in a clin ica l
trial. P a rticip a tio n in clinica l tria ls is
e s p e c ia lly e n co u ra g e d .
To fin d clinica l tria ls on lin e a t N C CN
m e m b e r in stitu tio n s, c lic k here:
n c c n .o rg /c lin ic a l tria ls /p h y s ic ia n .html

Expected Distress Symptoms (DIS-5)

NCCN Categories of Evidence and
C o n se n su s: All re co m m e n d a tio n s

Screening Tools for Measuring Distress (DIS-A)

a re C a te g o ry 2 A u n le ss o th e rw ise
s p e cifie d .

Psychosocial Distress Patient Characteristics (PIS-B)
Psychological/Psychiatric Treatment Guidelines (DIS-6)

S ee NCCN C a te g o rie s o f E vid e n ce
an d C o n se n su s

Social Work and Counseling Services fPIS-20)
Chaplaincy Services CDIS-21)
Recommendations for Implementation of Standards and Guidelines ('DIS-28'i
Recommended Readings for Implementation of Programs That Integrate
Psychosocial Care Into the Routine Care of Patients With Cancer (DIS-28)
Institutional Evaluation of Standards of Care (DIS-29^
For End of Life Issues. See the NCCN Guidelines for Palliative Care
For Cancer Pain. See the NCCN Guidelines for Adult Cancer Pain

The NCCN Guidelines® are a statement of evidence and consensus of the authors regarding their views of currently accepted approaches to treatment.
Any clinician seeking to apply or consult the NCCN Guidelines is expected to use independent medical judgm ent in the context of individual clinical
circumstances to determine any patient’s care or treatment. The National Comprehensive Cancer Network® (NCCN®) makes no representations or
warranties of any kind regarding their content, use or application and disclaims any responsibility for their application or use in any way. The NCCN
Guidelines are copyrighted by National Comprehensive Cancer Network®. All rights reserved. The NCCN Guidelines and the illustrations herein may
not be reproduced in any form without the express written permission of NCCN. ©2012.
Version 2.2013,10/11/12© National Comprehensive Cancer Network. Inc. 2012, A l rights reserved. The NCCN Guidelines" and this illustration may not be reproduced in any form without the express written permission of NCCN®,
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U p da te s in v e rs io n 2.2013 o f th e NCCN G u id e lin e s fo r D istre ss M anagem ent fro m V ersion 1.2013 in clu d e :
• The “ R ecom m ended R e ad ing s fo r Im p le m e n ta tio n o f P ro g ra m s th a t Integ rate P sych o so cia l Care in to th e R o utin e Care o f P atie nts w ith
C a n ce r” refere nce lis t w as m oved fro m the D is c u s s io n to th e a lg o rith m . (DI5-281
• The D is c u s s io n te x t w a s u p d a te d to c o rre s p o n d to th e cha ng es in th e a lg o rith m . (MS-1)
U p da te s in v e rs io n 1.2013 o f th e NCCN G u id e lin e s fo r D istre ss M anagem ent fro m V ersion 3.2012 in clu d e :

DIS-5
• U nder In te rv e n tio n s : “ S p iritu a l s u p p o rt” w as added.
DIS-A S cre e n in g T ools fo r M ea surin g D istre ss
• “ S u b sta n ce a b u s e ” w as added to th e lis t o f P h ysica l P roblem s.
DIS-B (P sych o so cia l D istre ss P atient C h a ra c te ris tic s )
• P e rio d s o f Increa sed V u ln e ra b ility : The se co n d b u lle t cha ng ed to “ D u ring d ia g n o s tic w o rk u p ” .
DIS-10 (M ood D isorde r)
• D anger to s e lf o r o th e rs : The th ird b u lle t changed to “ C o n s id e r re m o vin g s h a rp d a n g e ro u s o b je c ts ” .
DIS-14 (A d ju s tm e n t D iso rd e r)
• D anger to s e lf o r o th e rs : The th ird b u lle t changed to “ C o n s id e r re m o vin g aharp d a n g e ro u s o b je c ts ” .
DIS-18 (S ub stance -R elated D iso rd e r/A b u se )
• F ourth c o lu m n : The re co m m e n d a tio n c h a n g e d to “ R eferral to sp e cia lize d tre a tm e n t p ro g ra m s ” .
DIS-19 (P e rso n a lity D isorde r)
• E va lu a tio n : The fo llo w in g b u lle ts w ere c la rifie d as fo llo w s , “ T h re a te n in g b e h a v io r: D ra m a tic /h is trio n ic b e h a v io r: D e m an din g b e h a v io r” .
DIS-24 (C h a p la in cy S e rvice s: G uilt)
• F o o tn o te “ h” : “ R eferral to c le rg y o f p e rs o n ’s fa ith ” cha ng ed to “ C o n s id e r re fe rra l to c o m m u n ity re lig io u s re s o u rc e ” .

Version 2.2013,10/11/12© National Comprehensive Cancer Network. Inc. 2012, A l rights reserved. The NCCN Guidelines" and this illustration may not be reproduced in any form without the express written permission of NCCN®.
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“ DISTRESS”

Term “ d is tre s s ” w as ch o se n be cau se it :
• Is m ore acce ptab le and less s tig m a tiz in g th a n “ p s y c h ia tric ,”
“ p s y c h o s o c ia l,” o r “ e m o tio n a l”
• S o u n d s “ n o rm a l” and less e m b a rra ssin g
• Can be de fine d and m easured by se lf-re p o rt.

D e fin itio n o f D istre ss in C a n ce r (DIS-2)
Note: A ll recom m endations are category 2A u n less otherw ise indicated.
C lin ical Trials: N CCN believes that the best m anagem ent of any ca n ce r patient is in a clin ical trial. Participation in clin ical trials is esp ecially encouraged.
Version 2.2013,10/11/12© National Comprehensive Cancer Network. Inc. 2012, A l rights reserved. The NCCN Guidelines" and this illustration may not be reproduced in any form without the express written permission of NCCN®.
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DEFINITION OF DISTRESS IN CANCER

D istre ss is a m u ltifa c to ria l u n p le a sa n t e m o tio n a l exp erience o f a p s y c h o lo g ic a l (c o g n itive , be ha viora l,
e m o tio n a l), so cia l, a n d /o r s p iritu a l na ture th a t m ay in te rfe re w ith th e a b ility to cop e e ffe c tiv e ly w ith cancer,
its p h y s ic a l s y m p to m s and its treatm e nt. D istre ss e xte n d s a lo n g a c o n tin u u m , ra n g in g fro m com m o n
n o rm al fe e lin g s o f vu ln e ra b ility , sadness, and fe a rs to p ro b le m s th a t c an becom e d is a b lin g , s u c h as
d e p re ssio n , anxiety, panic, s o c ia l is o la tio n , and e xis te n tia l and s p iritu a l c ris is .

S tan dard o f Care fo r D istre ss M anagem ent IDIS-3)
Note: A ll recom m endations are category 2A u n less otherw ise indicated.
C lin ical Trials: N CCN believes that the best m anagem ent of any ca n ce r patient is in a clin ical trial. Participation in clin ical trials is esp ecially encouraged.
Version 2.2013,10/11/12© National Comprehensive Cancer Network. Inc. 2012, A l rights reserved. The NCCN Guidelines"'and this illustration may not be reproduced in any form without the express written permission of NCCN®.
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STANDARDS OF CARE FOR DISTRESS M ANAGEM ENT
• D istre ss s h o u ld be reco gn ized , m o n ito re d , d o cu m e n te d , and tre a te d p ro m p tly at all sta g e s o f disease and in all s e ttin g s.
• S cre e n in g s h o u ld id e n tify th e level and n a ture o f th e d is tre s s .
• A ll p a tie n ts s h o u ld be scree ne d fo r d is tre s s at th e ir in itia l v is it, a t a p p ro p ria te in te rva ls, and as c lin ic a lly in d ic a te d e sp e cia lly w ith
cha ng es in dise a se sta tu s (ie, re m is s io n , recurrence, p ro g re ssio n ).

• Distress should be assessed and managed according to clinical practice guidelines.
• In te rd is c ip lin a ry in s titu tio n a l c o m m itte e s s h o u ld be fo rm e d to im p le m e n t sta n d a rd s f o r d is tre s s m anagem ent.
• E d u ca tio n a l and tra in in g p ro g ra m s s h o u ld be d e velope d to e n su re th a t he a lth care p ro fe s s io n a ls and c e rtifie d ch a p la in s have
k n o w le d g e and s k ills in th e a sse ssm e n t and m an ag em en t o f d istre ss.
■ L ice n se d m ental he a lth p ro fe s s io n a ls and c e rtifie d ch a p la in s experience d in p s y c h o s o c ia l asp e cts o f ca n ce r s h o u ld be re a d ily
ava ila ble as s ta ff m em b ers o r by referral.
• M edical care c o n tra c ts s h o u ld in c lu d e re im b u rs e m e n t fo r se rv ic e s p ro vid e d b y m ental he alth pro fe ssio n a ls.
• C lin ic a l he alth o u tc o m e s m ea sure m ent s h o u ld in clu d e a sse ssm e n t o f th e p s y c h o s o c ia l d o m a in (eg, q u a lity o f life and p a tie n t and
fa m ily s a tisfa ctio n ).
• P atients, fa m ilie s , and tre a tm e n t te a m s s h o u ld be in fo rm e d th a t m a n ag em en t o f d is tre s s is an in te g ra l pa rt o f to ta l m edical care and
p ro v id e d w ith a p p ro p ria te in fo rm a tio n a b o u t p s y c h o s o c ia l se rv ic e s in th e tre a tm e n t c e n te r and the co m m u n ity.
■ Q u a lity o f d is tre s s m an ag em en t p ro g ra m s /s e rv ic e s s h o u ld be in c lu d e d in in s titu tio n a l c o n tin u o u s q u a lity im p ro v e m e n t (CQI) projects.

Note: A ll recom m endations are category 2A u n less otherw ise indicated.
C lin ical Trials: N CCN believes that the best m anagem ent of any ca n ce r patient is in a clin ical trial. Participation in clin ical trials is esp ecially encouraged.
Version 2.2013,10/11/12© National Comprehensive Cancer Network. Inc. 2012, A l rights reserved. The NCCN Guidelines" and this illustration may not be reproduced in any form without the express written permission of NCCN®.
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EXPECTED DISTRESS
SYMPTOMS

• P a tie n ts a t in cre a se d ris k o f
v u ln e ra b ility to d is tre s s 3
• S ig n s and s y m p to m s o f fea r
and w o rry a b o u t th e fu tu re

and uncertainty
> C o n ce rn s a b o u t illn e s s
> S ad ne ss a b o u t lo s s o f
usual he alth
> A nger, fe e lin g o u t o f
c o n tro l
> P o o r sle e p
> P o o r a p p e tite
> P o o r c o n c e n tra tio n
> P re o ccu p a tio n w ith
th o u g h ts o f illn e s s and
death
> Disease o r tre a tm e n t side
e ffe cts
> C o n ce rn s a b o u t s o c ia l role
(ie, as father, m o th e r)

INTERVENTIONS

NCCN Guidelines Index
Distress Management TOC
Discussion
RE-EVALUATION

• Clarify diagnosis, treatment options
and side effects
► Be sure patient understands
disease and treatment options
► Refer to appropriate patient
education materials (eg, NCCN
Treatment Summaries for Patients)
• Educate patient that points of
transition may bring increased
vulnerability to distress
• Acknowledge distress
■ Build trust

• Ensure continuity of care
■ Mobilize resources
• Consider medication to manage
symptoms:
► A n a lg e s ic s

(See NCCN Adult Cancer Pain
Guidelines)
► Anxiolytics
► Hypnotics
► Antidepressants
■ Support groups and/or individual
counseling
■ Family support and counseling
• Relaxation, meditation, creative
therapies (eg, art, dance, music)
• Spiritual support
• Exercise

S tab le o r
d im in is h e d
d is tre s s

C o n tin u e
--------► m o n ito ri ng
and s u p p o rt

M o n ito r
fu n c tio n a l level
and reevaluate
a t each v is it
See D istre ss
Increa sed o r
p e rs is te n t
d is tre s s

S core > 4 o r
m od era te to
seve re d is tre s s
(DIS-4)
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S C R EEN IN G T O O LS FOR M EASU R IN G DISTRESS

In s tru c tio n s : F irs t p le a s e c ir c le th e n u m b e r (0-10) th a t b e s t
d e s c rib e s h o w m u c h d is tre s s y o u h a ve been e x p e rie n c in g in
th e p a s t w e e k in c lu d in g to d a y .

Extreme distress

O

10
9 _

8
7

Second, please in d ica te if a n y o f the fo llo w in g has been a
p ro b le m fo r you in th e pa st w eek in c lu d in g today. Be sure to
ch e ck YES o r NO fo r each.

□ □
□ □
□ □
□ a
□ □
□ □

□ □
□ □
□ □
□ □

Child care

□

□

A ppearance

Housing

□

□

B athing/dressing

insurance/financial

□

□

Breathing

T ransportation

□

□

C hanges in urination

W ork/school

□

□

C onstipation

Treatm ent de cisions

□

□

D iarrhea

□

□

Eating

Familv Problems

□

□

Fatigue

Dealing w ith children

□

□

Feeling Swollen

a
a

G etting around

D e aling with partner

a

A b ility to have children

□

Fam ily health issues

□

□

Indigestion

□

□

M em ory/concentration

□

□

M outh sores

6
Emotional Problems
5 —

4
3

2
1

No distress

□ a
□ □
□ □
□ □
□ □
□ □

—

°o
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□

□

Depression
Fears
N ervousness
Sadness
W orry
Loss o f interest in
usual activities

Soiritual/reliaious

Fevers

□

a

N ausea

□

□

Nose dry/congested

□

□

Pain

□

□

Sexual

□

□

Skin dry/itchy

□

□

Sleep

□

□

S ubstance abuse

□

□

T ingling in ha nds/feet

c o n c e rn s
O th e r P ro b le m s :

Version 2.2013,10/11/12© National Comprehensive Cancer Network. Inc. 2012, A l rights reserved. The NCCN Guidelines" and this illustration may not be reproduced in any form without the express written permission of NCCN®.
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PSYCH O SO CIA L D ISTR ESS PATIENT CH A R A C TE R ISTIC S0

PATIENTS AT IN CREASED RISK FOR D IS T R E SS”

•
•
•
•
•
•

H isto ry o f p s y c h ia tric d is o rd e r/s u b s ta n c e ab use
H isto ry o f d e p re s s io n /s u ic id e a tte m p t
C o g n itiv e im p a irm e n t
C o m m u n ic a tio n b a rrie rs e
Severe c o m o rb id illn e sse s
S o cia l issu es
► F a m ily/ca re g ive r c o n flic ts
► Inadequate so cia l s u p p o rt
► L iv in g alon e
► F ina ncial pro b le m s
► L im ite d a cce ss to m ed ica l care
► Young o r d e p e n d e n t c h ild re n
► Y ou ng er age; w o m a n
>■ H isto ry o f abuse (p h ysica l, sexual)
► O th e r s tre s s o rs
• S p iritu a l/re lig io u s c o n ce rn s
• U n c o n tro lle d s y m p to m s

PERIODS OF IN CREASED VULNERABILITY

•
•
•
•
•
•
•
•
•
•
•
•
•

Finding a suspicious symptom
During diagnostic workup
Finding out the diagnosis
Awaiting treatment
Change in treatment modality
End o f treatment
Discharge from hospital following treatment
Transition to survivorship
Medical follow-up and surveillance
Treatment failure
Recurrence/progression
Advanced cancer
End o f life

c For site-specific sym ptom s w ith m ajor psychosocial con sequences, see H olland, JC, G reenberg, DB, Hughes, MD, et al. Q uick R eference for O ncology C linicians:
The P sychiatric and P sychological D im ensions o f C ancer S ym ptom M anagem ent. (Based on the NCCN D istress M anagem ent G uidelines). IPO S Press, 2006
Available at w w w .aoos-societv.ora.
dFrom the NCCN Palliative C are C linical Practice G uid elines in Oncology, A vailable at w w w .nccn.o ra.
^C om m unication barriers include language, literacy, and physical barriers.
Note: A ll recom m endations are category 2A u n less otherw ise indicated.
C lin ical Trials: N CCN believes that the best m anagem ent of any ca n ce r patient is in a clin ical trial. Participation in clin ical trials is esp ecially encouraged.
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SOCIAL WORK
AND COUNSELING
SERVICES 9

CATEGORY

Practical _
problem s

Referral by
oncology
team
to social
w ork
and
counseling
services

_P atient/fam ily/
assessm ent

PsychosociaJ_
problem s

TYPE OF PROBLEM
• Illness-related problem s
■ Concrete needs, including
housing, food, financial
assistance programs,
assistance w ith activities
of daily living,
transportation
Em ploym ent/school/career
concerns
C ultural/language issues
Family and caregiver
availability

/
\

■ Adjustm ent to illness
• Family and social
co nflict/isolation
• Treatment decisions, qualityof-life issues, and transitions
in care
• Advance directive
• Abuse and neglect
• Coping/com m unication
• Functional changes including
body image and sexuality
• End o f life/bereavement
• Cultural concerns
• Caregiver issues
(m obilizing caregiver
support)

Severe/ _
moderate

NCCN Guidelines Index
Distress Management TOC
Discussion

SOCIAL WORK AND COUNSELING
INTERVENTIONS
• Patient and family
counseling/psychotherapy
• Community resource
mobilization/linkage
• Problem-solving teaching
• Advocacy and patient/family
education

Mild ■

• Patient/family education
• Education/support group sessions
• Resource lists

Severe/ _
moderate

• Patient and family
counseling/psychotherapy, sex
counseling, and grief counseling
• Community resource mobilization
• Problem-solving teaching
• Advocacy and family/patient
education
• Education/support group
sessions
• Protective services
• Consider referral for
psychosocial/psychiatric
treatment
• Consider referral for chaplaincy
counseling

Follow-up and
com m unication
with prim ary
oncology team
and fam ily/
caregivers

>Patient/fam ily education
■E ducation/support group sessions
M ild ---------► • Resource lists
• Sex counseling
• G rief counseling

SSocial w ork and counseling services include m ental health services using psychological/psychiatric treatm ent guidelines.
Note: A ll re co m m e n d a tio n s are ca te g o ry 2A unless o th e rw is e in dicated.
C lin ica l T rials: NCCN b elieve s th a t th e b e st m anagem ent o f an y c a n ce r p atie nt is in a c lin ic a l tria l. P a rticip a tio n in c lin ic a l tria ls is e sp e cia lly enco ura ged.
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RECOMMENDATIONS FOR IMPLEMENTATION OF STANDARDS AND GUIDELINES
• Encourage establishm ent of in stitutional interdisciplinary com m ittees fo r im plem entation o f standards and guidelines
• C onduct m uiticenter tria ls that explore brief screening instrum ents and p ilo t treatm ent guidelines
• Encourage institutional CQI (continuous quality improvement) projects in quality o f distress management
■ Develop educational approaches to d istre ss management fo r staff, patients, and fam ily
RECOMMENDED READINGS FOR IMPLEMENTATION OF PROGRAMS THAT INTEGRATE
PSYCHOSOCIAL CARE INTO THE ROUTINE CARE OF PATIENTS WITH CANCER
• Bultz BD, G roff SL, Fitch M, et al. Im plem enting screening fo r
distress, the 6th vita l sign: a Canadian strategy fo r changing
practice. P sychooncology 2011;20:463-469. Available at:
http://www.ncbi.nlm.nih.gov/Dubmed/21456060.
• Carlson LE, Waller A, Mitchell AJ. Screening fo r distress and unmet
needs in patients w ith cancer: review and recom mendations. J Clin
Oncol 2012;30:1160-1177. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/22412146.
• Dolbeault S, B oistard B, Meuric J, et al. Screening fo r d istress and
supportive care needs during the initial phase o f the care process:
a qualitative description o f a clin ica l p ilo t experim ent in a French
cancer center. P sychooncology 2011 ;20:585-593. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/21425386.
• Fann JR, Ell K, Sharpe M. Integrating psychosocial care into cancer
services. J Clin Oncol 2012;30:1178-1186. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/22412139.
• Frost GW, Zevon MA, Gruber M, Scrivani RA. Use o f distress
therm om eters in an outpatient oncology setting. Health Soc Work
2011;36:293-297. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/22308881.
• Fulcher CD, Gosselin-Acom b TK. Distress assessment: practice
change through guideline im plem entation. Clin J Oncol Nurs
2007;11:817-821. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/18063540.

• Grassi L, Rossi E, Caruso R, et al. Educational intervention in cancer
outpatient clin ics on routine screening fo r emotional distress: an
observational study. Psychooncology 2011;20:669-674. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/21370316.
• Hendrick SS, Cobos E. Practical model fo r psychosocial care. J Oncol
Pract 2010;6:34-36. Available at:
http ://www. ncbi. nlm ,ni h. gov/pubmed/20539730.
• Loscalzo M, Clark KL, Holland J. Successful strategies fo r
im plem enting biopsychosocial screening. Psychooncology
2011;20:455-462. Available at:
http ://www. ncbi. nlm ,ni h. gov/pubmed/21456059.
• Lowery AE, Holland JC. Screening cancer patients fo r
distress:guidelines fo r routine im plem entation. C om m unity O ncology
2011;8:502-505. Available at:
http://w w w .com m unitvoncoloav.net/fileadm in/content images/co/articl
es/0811502.pdf.
• Mehta A, Hamel M. The developm ent and impact o f a new
Psychosocial O ncology Program. Support Care Cancer 2011;19:18731877. Available at: http://www.ncbi.nlm.nih.aov/pubmed/21681386.
■ Rodriguez MA, Tortorella F, St John C. Im proving psychosocial care
fo r im proved health outcomes. J Healthc Qual 2010;32:3-12. Available
at: http://www.ncbi.nlm.nih.gov/pubmed/20618566.

Note: A ll re c o m m e n d a tio n s are ca te g o ry 2A unless o th e rw is e in dicated.
C lin ic a l T rials: NCCN b elieve s th a t th e b e s t m anagem ent o f an y c a n c e r p atie nt is in a c lin ic a l tria l. P a rtic ip a tio n in c lin ic a l tria ls is e s p e cia lly enco ura ged.
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Overview
In the United States, it is estimated that a total of 1,638,910 new cancer
cases and 577,190 deaths from cancer will occur in 2012.1 All patients
experience some level of distress associated with the diagnosis of
cancer and the effects of the disease and its treatment regardless of
the stage of disease. Distress can result from the reaction to the
diagnosis of cancer and to the various transitions throughout the
trajectory of the disease including during survivorship. Clinically
significant levels of distress occur in a subset of patients, and
identification and treatment of distress are of the utmost importance.
These NCCN Distress Management guidelines discuss the
identification and treatment of psychosocial problems in patients with
cancer. They are intended to assist oncology teams identify patients
who require referral to psychosocial resources and to give oncology
teams guidance on interventions for patients with mild distress. These
guidelines also provide guidance for social workers, certified chaplains,
and mental health professionals that describe treatments and
interventions for various psychosocial problems as they relate to
patients with cancer.

Psychosocial Problems in Patients with Cancer
In the past two decades, dramatic advances in early detection and
treatment options have increased the overall survival rates in patients
of all ages with cancer. At the same time, these improved treatment
options are also associated with substantial long-term side effects:
fatigue, pain, anxiety, and depression are the most frequently reported
cancer-related symptoms that interfere with the patient's ability to
perform daily activities.2 In addition, the physiologic effects of cancer
itself and certain anti-cancer drugs can also be non-psychological
contributors to distress symptoms.3-6 Furthermore, cancer patients may
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have pre-existing psychological or psychiatric conditions that impact
their ability to cope with cancer.
The prevalence of psychological distress in individuals varies by the
type and stage of cancer as well as by patient age. In a study of 4496
cancer patients, Zabora and colleagues reported that the overall
prevalence of distress was 35,1%, which varied from 29.6% for patients
with gynecological cancers to 43.4% for patients with lung cancer.7The
prevalence of distress, depression, and psychiatric disorders has been
studied in many sites and stages of cancer.814 Overall, surveys have
found that 20-47% of newly diagnosed and recurrent cancer patients
show a significant level of distress. A recent metaanalysis reported that
30-40% of patients with various types of cancer have some
combination of mood disorders.15
Patients at increased risk for moderate or severe distress are those
with a history of psychiatric disorder, depression, or substance abuse
and those with cognitive impairment, severe comorbid illnesses,
uncontrolled symptoms, communication barriers, or social issues.
Social issues/risk factors include younger age; female; living alone,
having young children, and prior physical or sexual abuse.
Distress is a risk factor for non-adherence to treatment, especially with
oral medications. In women with primary breast cancer, Partridge and
colleagues observed that the overall adherence to tamoxifen decreased
to 50% in the fourth year of therapy and nearly one fourth of patients
may be at risk of inadequate clinical response due to poor adherence.16
In a meta-analysis, DiMatteo and colleagues found that noncompliance
was 3 times greater in depressed patients as compared to non
depressed patients.17 in addition to decreased adherence to treatment,
failure to recognize and treat distress leads to several problems:
patients may have trouble making decisions about treatment and they
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may make extra visits to the physician's office and emergency room,
which takes more time and causes greater stress for the oncology
team.1819 Distress in patients with cancer also leads to poorer quality of
life and can even negatively impact survival.14'20,21 Furthermore, cancer
survivors with untreated distress have poorer compliance with
surveillance screenings and are less likely to exercise and quit
smoking.22
Early evaluation and screening for distress leads to early and timely
management of psychological distress, which in turn improves medical
management.23,24 A recent randomized study showed that routine
screening for distress, with referral to psychosocial resources as
needed, led to lower levels of distress at 3 month than did screening
without personalized triage for referrals.25 Those with the highest level
of initial distress benefited the most. In addition, there is evidence from
randomized trials that psychologically effective interventions may lead
to a survival advantage in patients with cancer.26 Overall, early
detection and treatment of distress leads to
• better adherence to treatment
• better communication
• fewer calls and visits to the oncologist's office
■ avoidance of patients’ anger and development of severe anxiety or
depression
B arriers to D istress Management in Cancer
Less than half of distressed patients with cancer are actually identified
and referred for psychosocial help,27,28 Many patients with cancer who
are in need of psychosocial care are not able to get the help they need
due to the under-recognition of patient's psychological needs by the
primary oncology team and lack of knowledge of community
resources.29 The need is particularly acute in community oncologists’
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practices where there are few to no psychosocial resources, and
cancer care is often provided by short visits.
An additional barrier to patients receiving the psychosocial care they
require is the stigma associated with psychological problems. For many
centuries, patients were not told their diagnosis o f cancer due to the
stigma attached to the disease. Since the 1970s, this situation has
changed and patients are well aware of their diagnosis and treatment
options.30 However, patients are reluctant to reveal emotional problems
to the oncologist. The words “psychological," "psychiatric,” and
“emotional” are as stigmatizing as the word “cancer.” The word
“distress" is less stigmatizing and more acceptable to patients and
oncologists than these terms, but psychological issues remain
stigmatized even in the context of coping with cancer. Consequently,
patients often do not tell their physicians about their distress and
physicians do not inquire about the psychological concerns of their
patients. The recognition of patients’ distress has become more difficult
as cancer care has shifted to the ambulatory setting, where visits are
often short and rushed. These barriers prevent distress from receiving
the attention it deserves, despite the fact that this is a critical
component of the total care of the person with cancer.

NCCN Guidelines® for Distress Management
A major milestone in the improvement of psychosocial care in oncology
was made by the NCCN when it established a panel to develop clinical
practice guidelines, using the NCCN format. The panel began to meet
in 1997 as an interdisciplinary group. The clinical disciplines involved
were: oncology, nursing, social work and counseling, psychiatry,
psychology, and clergy, A patient advocate was also on the panel.
Traditionally, clergy have not been included on NCCN guideline panels,
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but the NCCN recognized that many distressed patients prefer a
certified chaplain.31

The New Standard of Care for Distress Management in
Cancer

The first step was to understand why this area has been so difficult to
develop. The panel members decided that words like "psychiatric" or
"psychological” are stigmatizing; patients and oncologists are reluctant
to label any symptoms or patients as such. The way around this barrier
was developed by using a term that would feel ‘‘normal" and
non-stigmatizing This led to the first published guidelines in 1999 for
the management of distress in cancer patients. This accomplishment
provided a benchmark, which has been used as the framework in the
handbook for oncology clinicians published by the IPOS press (The
International Psycho-Oncology Society).31

Psychosocial care had not been considered as an aspect of quality
cancer care until a 2007 Institute of Medicine (IOM) report, C an cer
C a re for the W hole P atient.34 The IOM report is based on the
pioneering work of the NCCN panel, which recommends screening for
distress and the development of a treatment plan with referrals as
needed to psychosocial resources.33 Psychosocial care is now a part of
the new standard for quality cancer care and should be integrated into
routine care,3435 The IOM report supported the work of the NCCN
Guidelines for Distress Management by proposing a model for the
effective delivery of psychosocial health services that could be
implemented in any community oncology practice:

The panel defines distress as a multifactorial unpleasant emotional
experience of a psychological (cognitive, behavioral, emotional), social,
and/or spiritual nature that may interfere with the ability to cope
effectively with cancer, its physical symptoms, and its treatment.
Distress extends along a continuum, ranging from common normal
feelings of vulnerability, sadness, and fears to problems that can
become disabling, such as depression, anxiety, panic, social isolation,
and existential and spiritual crisis.
Recommendations in the guidelines are based on evidence and on
consensus among panel members. In addition to the guidelines for
oncologists, the panel established guidelines for social workers,
certified chaplains, and mental health professionals (psychologists,
psychiatrists, psychiatric social workers, and psychiatric nurses).33

• Screening for distress and psychosocial needs
• Making a treatment plan to address these needs and implementing it
• Referring to services as needed for psychosocial care
• Reevaluating, with plan adjustment as appropriate.
In Canada, routine psychosocial care is part of the standard of care for
patients with cancer; emotional distress is considered the sixth vital
sign that is checked routinely along with pulse, respiration, blood
pressure, temperature, and pain.18,36
In August 2012, the Commission on Cancer (CoC) of the American
College of Surgeons (ACS) released new accreditation standards for
hospital cancer programs
(’http://www.facs org/cancer/coc/programsta ndards2012.html"], Their
patient-centered focus now includes screening all patients with cancer
for psychosocial distress.
The standards of care for managing distress proposed by the NCCN
Distress Management panel are broad in nature and should be tailored
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to the particular needs of each institution and group of patients. The
overriding goal of these standards is to ensure that no patient with
distress goes unrecognized and untreated. The panel based these
standards of care on quality improvement guidelines for the treatment
of pain.37 The standards of care developed by the NCCN Distress
Management panel, which can also be found in the guidelines, are:

provided with appropriate information about psychosocial services in
the treatment center and in the community.
» Finally, the quality of distress management programs/services should
be included in institutional continuous quality improvement (CQI)
projects.

• Distress should be recognized, monitored, documented, and treated
promptly at all stages of disease and in all settings.

Patients and families should be made aware that this new standard
exists and that they should expect it in their oncologist's practice. The
Alliance (http://www.wholecancerpatient.org/) is a coalition of
professional and advocacy organizations whose goal is to advance the
recommendations from the IOM report. Their website has hundreds of
psychosocial resources for health care professionals, patients, and
caregivers, searchable by state.

■ Screening should identify the level and nature of the distress.
• All patients should be screened to ascertain their levels of distress at
the initial visit, at appropriate intervals, and as clinically indicated,
especially with changes in disease status (remission, recurrence, or
progression).
• Distress should be assessed and managed according to clinical
practice guidelines.
• Interdisciplinary institutional committees should be formed to
implement standards for distress management.
• Educational and training programs should be developed to ensure
that health care professionals and certified chaplains have knowledge
and skills in the assessment and management of distress.
• Licensed mental health professionals and certified chaplains
experienced in the psychosocial aspects of cancer should be readily
available as staff members or by referral,
• Medical care contracts should include reimbursement for services
provided by mental health professionals.
• Clinical health outcomes measurements should include assessment
of the psychosocial domain (eg, quality of life and patient and family
satisfaction).
• Patients, families, and treatment teams should be informed that
management of distress is an integral part of total medical care and

Recommendations for Implementation of Standards
and Guidelines
Jacobsen and colleagues conducted a study in 2005 evaluating the
implementation of NCCN Guidelines for Distress Management by 15
NCCN member institutions.38 Eight institutions (53%) conducted routine
distress screening of some patient populations and an additional 4
institutions (27%) also preformed pilot testing of screening strategies.
However, concordance to NCCN Guidelines (screening all patients)
was observed in only 20% of the member institutions at that time.
Implementation of the IOM standards for integration of psychosocial
care into the routine care of patients with cancer can be improved by
providing feedback to oncology practices on the quality of their
psychosocial care. Quality indicators were thus developed by Jacobsen
and colleagues. They developed a patient chart audit which permits an
oncologists’ office or clinic to evaluate the quality of their psychosocial
care.39 The survey queries whether there is documentation that the
patient’s current emotional well-being was assessed and if there is
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documentation that any action was taken if the patient was identified as
having a problem. These quality indicators can be used widely to
determine the quality of psychosocial care given by a clinic or office.
The Quality Oncology Practice Initiative (QOPI) was started in 2002 by
the American Society of Clinical Oncology (ASCO) as a pilot project
(http://qopi.asco.org/proqram.htmn.40 This program became available to
all ASCO member medical oncologists in 2006. Jacobson’s
psychosocial quality indicators were added as part of the core
measures in the QOPI quality measures in 200841 in a recent analysis,
Jacobson and colleagues reported that practices participating in QOPI
demonstrated improved performance, with initially low-performing
practices showing the greatest improvement.41 Blayney and colleagues
from the University of Michigan Comprehensive Cancer Center recently
reported that QOPI can be adapted for use in practice improvement at
an academic medical center.42 The American Psychosocial Oncology
Society (APOS) has also adopted these quality indicators.43
The panel encourages the establishment of institutional interdisciplinary
committees to implement and monitor distress management. The
interdisciplinary committee should be responsible for evaluation of
standard care in distress management with continuous quality
improvement (CQI) studies. The panel encourages interdisciplinary CQI
studies to assess the quality of distress management programs as well
as the efficacy of standards of care and implementation of these NCCN
Guidelines for Distress Management and the new quality standard
established by the IOM report.34 The new CoC accreditation standards
for hospital cancer programs include screening all patients with cancer
for psychosocial distress, so psychosocial care is now on all institutions’
report cards.

NCCN Guidelines Index
Distress Management Table of Contents
Discussion

Multicenter randomized trials and pilot testing are needed to compare
the efficacy of brief screening instruments. Educational approaches
should be developed for medical staff, patients, and caregivers to
increase their awareness of the prevalence of distress and of
psychological interventions.
The MD Anderson Cancer Center published a report on their efforts to
implement the integration of psychosocial care into clinical care.44The
authors outline strategies they used to accomplish the required cultural
shift and describe the results of their efforts. Other groups have also
described their efforts towards implementing psychosocial screening in
various outpatient settings.43'45 Additional guidance for the
implementation of the new IOM standards has been published.30"52 In
Canada, a national approach has been used to implement screening for
distress. Their strategies have been described.53 Groups in Italy and
France have also described results of their preliminary efforts toward
the implementation of psychosocial distress screening.54” A reading list
for implementation of programs that integrate psychosocial care into the
routine care of patients with cancer is provided in these guidelines.
Overall, to implement the new standard of integrating psychosocial care
into the routine care of all patients with cancer, it is critical to have a
fast and simple screening method that can be used to identify patients
who require psychosocial care and/or referral to psychosocial
resources.52 The NCCN Distress Management panel developed such a
rapid screening tool, as discussed below.

Screening Tools for Distress and Meeting Psychosocial
Needs
Identification of a patient's psychological needs is essential to develop
a plan to manage those needs. Ideally, patients tell their oncologists
about their problems or they respond to the oncologist’s query about
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them. In routine clinical practice, time constraints and the stigma related
to psychiatric and psychological needs often leads to no discussion of
these issues. Screening tools have been found to be effective and
feasible in reliably identifying distress and the psychosocial needs of
patients.56-58 Mitchell and colleagues recently reported that ultra-short
methods (PHQ2 or the Distress Thermometer) were acceptable to
about three quarters of clinicians.59’60 Automated touch-screen
technologies have also been used for psychosocial screening of
patients with cancer.61-62 Recently, an internet-based program that
includes distress screening, reporting, referrals, and followup
components has been developed. The screening component was
validated in a trial of 319 community-based cancer survivors and
showed good psychometric properties.63
A recent metaanalysis compared 8 tools designed to screen for
depression in the cancer setting that had been validated by at least 2
separate studies.64 This analysis included the Hospital Anxiety and
Depression Scale (HADS), the Beck Depression Inventory version 2
(BDI-ll), and the Distress Thermometer (DT, discussed below).
The D istress Therm om eter (DT)
The NCCN Distress Management panel developed the distress
thermometer (DT), a now well known tool for initial screening, which is
similar to the successful rating scale used to measure pain: 0 (no
distress) to 10 (extreme distress). The DT serves as a rough initial
single-item question screen, which identifies distress coming from any
source, even if unrelated to cancer. The receptionist gives it to the
patient in the waiting room.
The word "distress” was chosen as described above, because it is less
stigmatizing and more acceptable to patients and oncologists than
other terms such as psychiatric, psychosocial, or emotional. Using this
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non-stigmatizing word diminishes clinicians' concerns that the patient
will be embarrassed or offended by these questions. Asking an
objective question such as, “How is your pain today on a scale of 0 to
10?" made it easier and more comfortable for caregivers to learn about
patients' pain. Similarly, asking patients, “How is your distress today on
a scale of 0 to10?” opens a dialogue with the oncologist or nurse for a
discussion of emotions that is more acceptable.
The patient in the waiting room places a mark on the DT scale
answering: "How distressed have you been during the past week on a
scale of 0 to 10?” Scores of 4 or higher suggest a level of distress that
has clinical significance. If the patient's distress level is mild (score is
less than 4 on the DT), the primary oncology team may choose to
manage the concerns by usual clinical supportive care management. If
the patient’s distress level is 4 or higher, the nurse looks at the problem
list (see below) to identify key issues of concern and asks further
questions to determine to which resources (mental health, social work
and counseling, or chaplaincy services) the patient should be referred.
The DT has been validated by several studies in patients with different
types of cancer and has revealed concordance with the Hospital
Anxiety and Distress Scale (HADS).56,65'71 The DT has shown good
sensitivity and specificity. The needs assessment surveys performed in
ambulatory clinics using these screens show 20-40% of patients have
significant levels of distress. Two studies validated a version of the DT
with an expanded problems list.7273 Tuinman and colleagues validated
the DT with the 46-item problem list in a cross-sectional group of 227
cancer patients.73 Graves and colleagues validated the DT with an
adapted problems list with two new problem categories (information
concerns and cognitive problems) in lung cancer patients.72 The DT is
also a useful tool for screening distress among bone marrow transplant
patients.74'75 The DT had acceptable overall accuracy and greater
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sensitivity and specificity when compared to the Center for
Epidemiological Studies-Depression Scale (CES-D) in the assessment
of depression in patients undergoing bone marrow transplants.74
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reported memory problems.87 A better understanding of the
mechanisms that cause cancer-related cognitive impairment is
essential for the development of treatments to improve cognitive
function and quality of life in patients with cancer.76,77,88

The Problem List
The screening tool developed by the NCCN Distress Management
panel includes a 39-item Problem List, which is on the same page with
the DT. The Problem List asks patients to identify their problems in five
different categories: practical, family, emotional, spiritual/religious, and
physical (see Screening Tools for Measuring Distress in the guidelines).
The completed list is reviewed by the nurse, because he/she is present
at all visits and is the likely person to ask clarifying questions. Social
workers are often not immediately available in busy clinics.
C ognitive Im pairm en t
'Memory/concentration problems” is one item on the Problem List.
Cognitive impairment is common in patients with primary central
nervous system (CNS) cancers, due to both the effects of brain tumors
themselves and the effects of treatment targeted to the brain.76,77
Recent evidence has shown that chemotherapy-related cognitive
dysfunction is also prevalent in patients with non-CNS cancers and
without brain metastases.78'31 Chemotherapy can cause subtle cognitive
changes, studied primarily in breast and lymphoma patients. It can
continue over years and at times, when more severe, can impact
quality of life and function. The underlying mechanisms for
chemotherapy-induced cognitive changes are not known. Recent
studies have reported elevated levels of cytokines or DNA damage as
some of the possible mechanisms.81 In addition, evidence suggests that
cancer itself and therapies other than chemotherapy, such as hormone
therapy, can cause cognitive impairments in patients with cancer.83'86 A
recent national cross-sectional study found that a history of cancer is
independently associated with a 40% increase in the likelihood of self

There is no standard treatment for the management of cognitive
changes in patients with cancer. Cognitive behavior therapy, cognitive
rehabilitation programs, and exercise may be effective interventions to
improve cognitive function in patients with cancer8990 In addition, some
studies have shown that the use of psychostimulants such as
methylphenidate and modafinil improved cognitive function in patients
with cancer.91'93 Donepezil, a reversible acetylcholinesterase inhibitor
(approved to treat mild to moderate dementia in patients with
Alzheimer’s disease) also improved cognitive function, mood, and
health-related quality of life in patients with primary low-grade glioma.94
Further placebo controlled trials are needed to confirm these
preliminary findings.
In October 2006 the International Cognition and Cancer Task Force
(ICCTF), comprised of a multidisciplinary group of health professionals
and health advocates, was formed. The mission of ICCTF is to advance
understanding of the impact of treatment-related cognitive and
behavioral functioning in patients with non-CNS cancers.’ 5 ICCTF also
has a web site (www.icctf.com1 to provide up-to-date information to
both physicians and patients seeking assistance in the management of
cognitive symptoms associated with cancer treatment.
Fertility
Another item on the Problem List is the “ability to have children."
Chemotherapy and radiation therapy also have an impact on the fertility
of patients, especially in those who are of child-bearing age.96
Therefore, the panel has included “ability to have children" as one of
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the items under the family problems category. MvOncofertilitv.org is a
useful patient education resource for those who are concerned about
the possible effect of cancer treatment on their fertility.

Sujbsfance Abuse
For the 2013 version of these guidelines, the panel added substance
abuse to the list of possible physical problems. Substance abuse in
patients with cancer who do not have a history of abuse or addiction is
rare and is usually caused by insufficient symptom control. Improving
symptom control often alleviates the substance dependence. This
problem is discussed in more detail below in Substance-Related
Disorder/Abuse.

Initial Evaluation and Treatment by Oncology Team
The panel recommends that all patients be assessed in the waiting
room using a simple screening tool. While there are several types of
screening tools, the DT and the accompanying Problem List are
recommended to assess the level of distress and to identify causes of
distress. If the patient's distress is moderate or severe (thermometer
score of 4 or more), the oncology team must recognize that score as a
trigger to a second level of questions should prompt referral to a mental
health professional, social worker, or spiritual counselor, depending on
the problems identified in the Problem List. Common symptoms that
require further evaluation are: excessive worries and fears, excessive
sadness, unclear thinking, despair and hopelessness, severe family
problems, social problems, and spiritual or religious concerns.
Mild distress (DT score of less than 4) is routinely managed by the
primary oncology team and represents what the panel terms "expected
distress" symptoms. The symptoms that the team manages are fear,
worry, and uncertainty about the future; concerns about the illness;
sadness about loss of good health; anger and the feeling that life is out
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of control; poor sleep, poor appetite, and poor concentration;
preoccupation with thoughts of illness, death, treatment, and side
effects; and concerns about social roles (eg, as mother, father). Most
patients experience these symptoms at the time of diagnosis and
during arduous treatment cycles. They might persist long after the
completion of treatment. For instance, minor symptoms are often
misinterpreted by survivors as a sign of recurrence, which causes fear
and anxiety until they are reassured.
The primary oncology team is the first to deal with these painful
problems. The oncologist, nurse, and social worker each have a critical
role. First and foremost is the quality of the physician s communication
with the patient, which should occur in the context of a mutually
respectful relationship so that the patient can learn the diagnosis as
well as understand the treatment options and side effects.57’98 Adequate
time should be provided for the patient to ask questions and for the
physician to put the patient at ease. When communication is done well
at diagnosis, the stage is set for future positive trusting encounters. It is
important to ensure that the patient mentally grasps what has been
said. Information may be reinforced with drawings or by taping the
session and giving the tape to the patient. Communication skills training
for oncology professionals who teach, for example, how to discuss
prognosis and unanticipated adverse events and howto reach a shared
treatment decision may be very helpful. Communication skills training
was recently reviewed by Kissane et a l."
It is important for the oncology team to acknowledge that this is a
difficult experience for the patient and that distress is normal and
expected. Being able to express distress to the staff helps provide relief
to the patent and builds trust. The team needs to ensure that social
supports are in place for the patient and that he or she knows about
community resources such as support groups, teleconferences, and
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help lines. The IOM report contains a list of national organizations and
their toll-free numbers.34 Some selected organizations that provide free
information services to cancer patients are:
• American Cancer Society (www.cancer.org)
• American Institute for Cancer Research fwww.aicr.org')
• American Psychosocial Oncology Society (www.apos-societv.om)
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Follow-up at regular intervals or at transition points in illness is an
essential part of the NCCN Guidelines for Distress Management and
the IOM model for care of the whole patient. This reassessment is
particularly important in elderly cancer patients.100

Psychological/Psychiatric Treatment by Mental Health
Professionals

(APOS provides a toll-free Help Line [1-866-276-7443] to which

P sychosocial Interventions

patients and their caregivers can be referred to help them find

Psychosocial interventions have been effective in reducing distress and
improving overall quality of life among cancer patients.34,35 The 2007
IOM report noted that there is a strong evidence base that supports the
value of psychosocial interventions in cancer care.34 The review
examined the range of interventions (psychological, social, and
pharmacologic) and their impact on any aspect of quality of life,
symptoms, or survival. The extensive review found randomized clinical
trials, systematic reviews, and meta-analyses supporting the conclusion
that psychosocial aspects must be integrated into routine cancer care in
order to give quality cancer care. Cognitive-behavioral therapy (CBT),
supportive psychotherapy, and family and couples therapy are the three
key types of psychotherapies discussed in the IOM report.34

psychological resources in their community.)
• CancerCare (www.cancercare.ora)
• National Cancer Institute (www.cancer.aov)
• Cancer.net, sponsored by ASCO fwww.cancer.net).
• Cancer Support Community
(’http://w w w .cancersuD p0rtc0m m unitv.0rq)

Clinicians should be aware of the evidence-supported interventions
available for the management of distress. In addition to these NCCN
Guidelines for Distress Management (www.nccn.oro). the following
clinical practice guidelines will be useful to clinicians, including the
oncology team:
• Clinical practice guidelines for the psychosocial care of adults with
cancer have been developed by the Australian National Breast
Cancer Centre and the National Cancer Control Initiative
(h ttp ://w w w .n h m rc.aov.a u /a uide line s/D u b lica tio n s/cD 9 0).

• National Cancer Institute and several partners have developed a web
site that provides information about research-tested intervention
programs (http://rtips.cancer g o v/rtip s /in d e x .d o ).

C ognitive-B ehavioral Therapy
CBT involves relaxation, enhancing problem-solving skills, and the
identification and correction of inaccurate thoughts associated with
depressed feelings. In randomized clinical trials, CBT has been shown
to effectively reduce psychological symptoms (anxiety and
depression)101,182 as well as physical symptoms (pain and fatigue)103 in
patients with cancer. A recent systematic review, however, concluded
that data on the efficacy of CBT in patients with advanced cancer is
lacki ng.104
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Ferguson and colleagues have developed a brief CBT intervention
(Memory and Attention Adaptation Training [MAAT]) aimed at helping
breast cancer survivors manage cognitive dysfunction associated with
adjuvant chemotherapy.105 In this single-arm pilot study, improvements
in self reporting of cognitive function, quality of life, and standard
neuropsychological test performance were observed in all patients (29
women at an average of 8 years after adjuvant chemotherapy for stage
l-ll breast cancer). The authors have since performed a randomized
study to evaluate the efficacy of MAAT.89 They found that patients in the
intervention arm had improved verbal memory performance and
spiritual well-being.
Supportive P sychotherapy
Supportive psychotherapy, aimed at flexibly meeting patients' changing
needs, is most widely used. Different types of group psychotherapy
have been evaluated in clinical trials among cancer patients.
Supportive-expressive group therapy has been shown to improve
quality of life and psychological symptoms, especially improvements in
mood and pain control in patients with metastatic breast cancer. 106-107
Cognitive-existential group therapy has been found to be useful in
women with early-stage breast cancer receiving adjuvant
chemotherapy.108 Meaning-centered group psychotherapy, designed to
help patients with advanced cancer sustain or enhance a sense of
meaning, peace, and purpose in their lives (even as they approach the
end of life), has also been shown to reduce psychological distress
among patients with advanced cancer.109'110 Recently, dignity therapy
has been assessed in a randomized controlled trial of patients with a
terminal diagnosis (not limited to cancer).111 Although there was no
significant improvement in levels of distress in patients receiving dignity
therapy as measured by several scales, significant improvements,
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specifically for depression and self-reported aspects of quality-of-life,
were seen.
Fam ily and C ouples Therapy
A cancer diagnosis causes distress in partners and family as well as
the patient. Psychosocial interventions aimed at patients and their
families together might lessen distress more effectively than individual
interventions. In a longitudinal study of couples coping with early-stage
breast cancer, mutual constructive communication was associated with
less distress and more relationship satisfaction for both the patients and
partners compared to demand/withdraw communication or mutual
avoidance, suggesting that training in constructive communication
would be an effective intervention.112
Family and couples therapy has not been widely studied in controlled
trials. A small randomized trial was recently reported in which patients
and their caregivers received 8 emotionally focused therapy sessions or
standard care.113 Significant improvements in marital functioning and
patient experience of empathetic care by the caregiver were seen.
These effects were maintained 3 months after the intervention. In
addition, a randomized controlled trial showed that family-focused grief
therapy can reduce the morbid effects of grief in families with terminally
ill cancer patients.114 A recent systematic review of 23 studies that
assessed the efficacy of psychosocial interventions for couples affected
by cancer found evidence that couples therapy might be at least as
effective as individual therapy.115

Pharmacologic Interventions
Research suggests that antidepressants and antianxiety drugs are
beneficial in the treatment of depression and anxiety in adult cancer
patients.116'122 In randomized controlled trials, alprazolam123124 (a
benzodiazepine) and fluoxetine125126 (a selective serotonin reuptake
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inhibitor [SSRI]) have been effective in improving depressive symptoms
in cancer patients. SSRIs are widely used for depression and anxiety
symptoms.
Psychostimulant drugs help in the management of fatigue.1271151
Methylphenidate is likely effective for the treatment of cancer-related
fatigue, but additional trials are needed. Wakefulness-promoting agents
such as modafinil are also commonly used to treat fatigue in patients
with cancer, but their efficacy remains to be shown conclusively.127
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disorder, substance abuse-related disorder, and personality disorder.
For the 2012 guidelines, the panel developed new guidelines to
address psychotic disorder and schizophrenia. Psychotropic drugs are
recommended throughout the guidelines to treat psychiatric disorders.
It is important to note that these drugs can sometimes interact with
anticancer therapies and cause adverse effects. A recent article
reviews some of these interactions and discusses other challenges in
treating cancer in patients with severe mental illness.130

Dementia and Delirium

Psychological/Psychiatric Treatment Guidelines
Patients scoring 4 or higher on the DT during any visit to the oncologist
are referred to the appropriate supportive service (mental health, social
work and counseling, or chaplaincy services) based on the identified
problem.
Mental health professionals are expected to conduct a psychological or
psychiatric evaluation that includes an assessment of the nature of the
distress, behavior and psychological symptoms, psychiatric history, use
of medications, pain, fatigue, sleep disturbances, other physical
symptoms, cognitive impairment, body image and sexuality, and
capacity for decision making and physical safety. A psychiatrist,
psychologist, nurse, advanced practice clinician, or social worker may
perform the evaluation. All of these professionals are skilled in mental
health assessment and treatment. The Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)
classification of mental disorders is used to identify the psychological
and psychiatric disorders that commonly occur in patients with cancer.

Dementia and delirium are cognitive impairments that can severely
impair the patient’s decision-making capacity. Dementia is a permanent
cognitive impairment. It is not a common complication of cancer
treatment, but is often present in elderly patients as a comorbid
condition.131'132 Dementia can be treated with cognitive rehabilitation,
with or without medications, though treatment is largely management of
behavior. Delirium is a short-term cognitive impairment. It is usually
reversible and occurs in cancer treatment related to any toxic state, and
it often related to medication, particularly opioids.133 Delirium is
managed by attention to safety, modification of opioids or other
medications, neuroleptics, and family support and education.134 The
United Kingdom’s National Institute for Health and Clinical Excellence
(NICE) issued detailed guidelines for the diagnosis, prevention, and
management of delirium.135 In addition, a recent comprehensive review
in The Journal o f Clinical O ncology Special Series on Psychosocial
Care in Cancer by Breitbart and Alici136 describes the evidence base for
recommended pharmacologic and non-pharmacologic treatments for
delirium in patients with cancer.

The panel has developed evaluation and treatment guidelines for the
most commonly encountered psychiatric disorders: dementia, delirium
(encephalopathy), mood disorder, adjustment disorder, anxiety
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Mood and Adjustment Disorders
Mood disorders such as depression and adjustment disorder (mixed
anxiety and depressive symptoms) are common in patients with cancer
and can be debilitating. Patients with uncontrolled mood and
adjustment disorders can develop suicidal tendencies. The incidence of
suicide among cancer patients in the United States is twice that of the
general population.137'13’ Older patients and men with head and neck
cancer or myeloma seem to have a higher risk of suicide,140
Mood disorder is usually managed with psychotherapy or an
antidepressant with or without anxiolytics. The evidence for these
treatments has been described.35,141'143 In particular, a recent review by
Li et al144 in The Journal o f C linical O ncology Special Series on
Psychosocial Care in Cancer comprehensively describes the evidence
for recommended pharmacologic and psychosocial interventions for
treating depression in patients with cancer. Referral to social work and
counseling services and chaplaincy services may also be considered
Patients considered a danger to themselves or others should be
considered for psychiatric consultation. Increased monitoring is also
warranted, and the removal of dangerous objects should be
considered. Psychiatric treatment and hospitalization may sometimes
be necessary.

Anxiety Disorder
Anxiety occurs at times in most patients with cancer,145 The diagnosis
of cancer and the effects of the disease and its treatment are obvious
sources of unease; however, anxiety may also be related to
physiological aspects of the medical condition (eg, hormone-secreting
tumors; effects of certain types of medications [bronchodilators];
withdrawal from alcohol or narcotics; pain or some other distressing
physical symptom). Anxiety may not be severe or problematic, but
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needs to be addressed when it becomes disruptive. After ruling out
medical causes, the clinician should assess symptoms to determine the
particular nature of the anxiety disorder(s). Generalized anxiety
disorder is usually pre-existing and may be exacerbated by illness.
Panic disorder may recur during illness in a person with previous panic
symptoms. Post-traumatic stress disorder may develop after arduous
cancer treatments or during a cancer treatment that triggers a traumatic
memory of a past frightening event. Obsessive-compulsive disorder is a
pre-existing disorder that results in difficulty in making decisions,
ruminative thoughts about illness, and fearfulness to take medication.
Some patients develop phobias of needles, hospitals, and blood or
conditioned nausea/vomiting related to chemotherapy.
Chemotherapy-induced nausea and vomiting should be managed
according to the NCCN Guidelines for Antiemesis.
The NCCN Distress Management Panel recommends psychotherapy
with or without an anxiolytic and/or an antidepressant for the treatment
of anxiety (category 1), after eliminating medical causes. If the anxiety
responds to initial treatment, follow-up should occur with the primary
oncology team and family/caregivers, if no response is noted, the
patient should be re-evaluated and treated with different medications (a
neuroleptic should be considered) with continued psychotherapy,
support, and education. If there is still no response, then the patient
should be evaluated for depression and other psychiatric comorbidity.
The evidence for the effectiveness of these treatments has been
reviewed.34,35 In a recent review in The Journal of Clinical Oncology
Special Series on Psychosocial Care in Cancer, Traeger et al146 give a
comprehensive description of the evidence for recommended
pharmacologic and non-pharmacologic treatments for anxiety in
patients with cancer.
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Substance-Related Disorder/Abuse
Substance abuse is rare among cancer patients who do not have a
history of active abuse or addiction to opioids, alcohol, or tobacco.
Substance abuse or dependence developing during the course of the
treatment may be due to insufficient symptom control and can be
treated by improving symptom control. In patients with a history of
substance abuse, its impact on cancer treatment should be assessed.
After appropriate detoxification regimens, psychoeducation should be
provided with or without cognitive-behavioral psychotherapy and with or
without medication. Referral should be made to risk reduction,
substance abuse management, or specialized treatment programs as
needed. Patients with a history of substance abuse should be
monitored for signs and symptoms of relapse.

Personality Disorder
Patients with cancer may have a pre-existing personality disorder,
which can be exacerbated by the stress of cancer and its treatment.147
When a personality disorder is suspected, the patient should be
evaluated by a mental health professional, and safety and decision
making capacity should be assessed. If possible, any medication or
other factors that could be aggravating the condition should be
modified. A coordinated behavioral, psychological, and medical
treatment plan, with or without medication, should be developed with
the health care team.

NCCN Guidelines Index
Distress Management Table of Contents
Discussion

particular, steroids or steroid withdrawal can induce psychosis, which
may be relieved by modifying dose or changing steroid choice.14S’149
When a patient in a long-term psychiatric facility develops cancer, there
is a need for coordination of care between the psychiatric facility and
the inpatient cancer facility Special attention should be paid to the
transition of a psychiatric patient who needs inpatient oncology care.
The issues around continuation of psychotropic medications, when they
must be stopped for surgery or chemotherapy and when they should be
restarted, are important issues in total care.
When a psychotic episode occurs in a patient with cancer, differential
diagnoses must be ruled out. Delirium is often confused with psychotic
disorder and is much more common; dementia, mood disorder, and
substance abuse/withdrawal should also be considered. When
psychotic disorder or schizophrenia is diagnosed, several interventions
can be considered: 1) anti-psychotic medication, 2) medication for
mood, 3) transfer to a psychiatric unit/hospital, and 4) electroconvulsive
therapy (ECT) for psychotic depression/mania or catatonia.
In ECT, electrical currents are passed through the brain in a controlled
fashion, inducing a brief seizure. ECT appears to be an effective
treatment of psychotic depression, mania, catatonia, and other
psychiatric disorders.150' 154 Although the use of ECT in cancer has not
been well studied, several case studies suggest that it can be safe and
effective.155'159

Psychotic Disorder and Schizophrenia

Social Work and Counseling Services

Psychotic disorder includes hallucinations, delusions, and/or thought
disorders; patients with recurrent psychotic episodes have
schizophrenia. Psychotic disorder and schizophrenia can exist as
comorbidities in patients with cancer and can also be caused or
exacerbated by cancer and its associated stress and treatment. In

Social work and counseling services are recommended when a patient
has a psychosocial or practical problem. Practical problems are
illness-related concerns; concrete needs (eg, housing, food, financial
assistance, help with activities of daily living, transportation);
employment, school, or career concerns; cultural or language issues;
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and caregiver availability. The guidelines outline interventions that vary
according to the severity of the problem.
Psychosocial problems are adjustment to illness; family conflicts and
social isolation; difficulties in decision making; quality-of-life issues;
concerns about advance directives; domestic abuse and neglect; poor
coping or communication skills; concerns about functional changes (eg,
body image, sexuality); and issues pertaining to end of life and
bereavement (including cultural and caregiver concerns)
Social workers intervene in mild psychosocial problems by using patient
and family education, support groups, and/or sex or grief counseling
and by suggesting available local resources. For moderate to severe
psychosocial problems, counseling and psychotherapy are used
(including sex and grief counseling); community resources are
mobilized; problem solving is taught; and advocacy, education, and
protective services are made available.

Spiritual Care and Chaplaincy Services
Many patients use their religious and spiritual resources to cope with
illness160; many cite prayer as a major help. In addition, the diagnosis of
cancer can cause an existential crisis, making spiritual support of
critical importance. Balboni et al161 surveyed 230 patients with
advanced cancer treated at multiple institutions who had failed to
respond to first-line chemotherapy. The majority of patients (88%)
considered religion as somewhat or very important. Nearly half of the
patients (47%) reported receiving very minimal or no support at all from
their religious community and 72% reported receiving little or no
support from their medical system.151 Importantly, patients receiving
spiritual support reported a higher quality of life. Religiousness and
spiritual support have also been associated with improved satisfaction
with medical care. Astrow et al162 found that 73% of patients with
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cancer had spiritual needs, and that patients whose spiritual needs
were not met reported lower quality of care and lower satisfaction with
their care. A recent multi-institution study of 75 patients with cancer and
339 oncologists and nurses (the Religion and Spirituality in Cancer
Care Study) found that spiritual care had a positive effect on patientprovider relationships and the emotional well-being of patients.163
The panel has included chaplaincy services as part of psychosocial
services All patients should be referred for chaplaincy services when
their problems are spiritual or religious in nature or when they request
it. The panel identified 11 issues related to illness for which people
often seek chaplaincy services. A treatment guideline is available for
each of these issues: grief, concerns about death and the afterlife,
conflicted or challenged belief systems, loss of faith, concerns with
meaning and purpose of life, concerns about relationship with deity,
isolation from the religious community, guilt, hopelessness, conflict
between beliefs and recommended treatments, and ritual needs.
The certified chaplain evaluates the problem and may offer spiritual or
philosophical reading materials, spiritual advice and guidance, prayer,
and/or rituals. For patients who are members of a religious community,
the certified chaplain could also serve as a liaison between the patient
and the religious community or assist the patient to access spiritual
resources. Some patients may be referred for social work and
counseling or mental health services if the problems indicate a need for
more than spiritual counseling. In addition, patients whose concerns are
not allayed may be referred for mental health evaluation while
continuing to receive spiritual counseling if they wish. In particular,
patients who experience guilt or hopelessness should also be
evaluated by mental health professionals for further assessment since
they may also have severe depressive symptoms or suicidal ideations.
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A palliative/supportive care consultation can also be important in
patients who express hopelessness.
A consensus conference on improving the quality of spiritual care as a
dimension of palliative care was held in February 2009. The report from
this conference provides recommendations for health care
professionals on the integration of spiritual care into the patient’s overall
treatment plan.164 The inclusion of a certified chaplain in the
interdisciplinary team is critical for the implementation of spiritual care
into routine clinical practice.
The following guidelines on religion and spirituality in cancer care may
be useful for clinicians and patients:
• National Consensus Project Clinical Practice Guidelines for Quality
Palliative Care, Second Edition, 2009. These guidelines provide a
framework to acknowledge the patient’s religious and spiritual needs
in a clinical setting. Spiritual, Religious, and Existential Aspects of
Care are included as 1 of the 8 clinical practice domains in these
guidelines: http://www.nationalconsensusproiect.org/auideline.pdf.
• The National Cancer Institute’s comprehensive cancer information
database (PDQ) has information on “Spirituality in Cancer Care” for
patients
(http ://www. cancer. qov/cancertopics/pdq/supportivecare/spiritualitv/P
atierit) and for health care professionals
fhttp ://www.cancer.gov/cancertopios/pda/supportivecare/spiritualitv/H
ealthProfessionan.

Oncologist Burnout
The stress and demands of treating patients with cancer and making
life and death decisions daily often cause psychologic distress for
oncologists. This distress in turn can cause depression, anxiety, and
fatigue, it can also cause burnout, characterized by a lack of

NCCN Guidelines Index
Distress Management Table of Contents
Discussion

enthusiasm for work, feelings of cynicism, and a low sense of personal
accomplishment with work, in as many as 28% to 38% of oncologists,
as recently reviewed by Shanafelt and Dyrbye.165 Burnout can affect
medical care, physician-patient relationships, and personal
relationships and can lead to substance abuse and even suicide.
Strategies for avoiding and reducing burnout discussed in the review
include training in self-care, personal wellness, mindful meditation, and
behavioral change by medical schools, residency programs, hospitals,
and private practices. Organizational strategies can also create a
culture that is less stressful and less conducive of oncologist burnout.

The Journal o f Clinical Oncology Special Series on
Psychosocial Care in Cancer
In April 2012, the Journal o f C linical O ncology published a Special
Series on psychosocial care fhttp://ico.ascopubs.org/content/30/11.tocV
demonstrating that this topic is now getting the attention is has so long
deserved. The Special Series includes a review by Jacobsen and
Wagner that describes how the new standard of psychosocial care, the
development of clinical practice guidelines for psychosocial care such
as these NCCN guidelines, and the establishment of indicators to
measure the quality of psychosocial care can help increase the number
of patients with cancer receiving psychosocial care.166 Integral to the
successful integration of psychosocial care into routine cancer care is a
distress screening program. In the Special Series, Carlson et al™
present their recommendations for implementing such a program, and
Fann et al51 discuss the organizational challenges of this new integrated
care model, with a focus on the collaborative care service model,
Research on psychosocial care in cancer treatment has expanded
greatly in recent years. This fact attests to the growing awareness of
the importance of the topic, both by health care professionals and by
the public.167 The Special Series includes reviews of evidence-based
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interventions for 3 common psychosocial problems in patients with
cancer: depression, anxiety, and delirium.136,144’146
Worries and concerns about cancer do not necessarily end with the end
of acute care. The Special Series thus also includes articles addressing
the psychosocial needs of adolescent and young adult (AYA) and adult
cancer survivors.168,169 An article on the psychosocial needs of care
givers is also included.170
In addition, an article was included on ‘oncologist burnout,' a problem
with an estimated prevalence of 28% to 38%, depending on medical
specialty.165 The Special Series concludes with a review and meta
analysis of studies that provide evidence for the development of an
appropriate curriculum for communication skills training of oncologists.,9
Patient benefit from such training (ex, better adherence to treatment)
has yet to be demonstrated.

Summary
Psychosocial care is increasingly being recognized as an integral
component of the clinical management of cancer patients. Treating
distress in cancer benefits the patients and their families/caregiver as
well as the treating staff and helps improve the efficiency of clinic
operations. For patients with cancer, integration of mental health and
medical services is critically important. Spirituality and religion also play
an important role for many patients with cancer in coping with the
diagnosis and the illness.
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psychosocial service, if needed. The choice of which psychological
service is needed is dependent on the problem areas specified on the
Problem List. Patients with practical and psychosocial problems should
be referred to social workers; those with emotional or psychological
problems should be referred to mental health professionals including
social workers; spiritual concerns should be referred to certified
chaplains.
Health care contracts often allow these services to “fall through the
cracks” by failing to reimburse for them through either behavioral health
or medical insurance. Reimbursement for services to treat psychosocial
distress must be included in medical health care contracts to prevent
fragmentation of mental health services for the medically ill. Outcomes
research studies that include quality-of-life assessment and analysis of
cost-effectiveness are needed to help make this a reality.
The primary oncology team members (oncologist, nurse, and social
worker) are central to making this model work. It is critical for at least
one team member to be familiar with the mental health, psychosocial,
and chaplaincy services available in the institution and the community.
A list of the names and phone numbers for these resources should be
kept in all oncology clinics and should be updated frequently.
Education of patients and families is equally important to encourage
them to recognize that control of distress is an integral part of their total
cancer care.

The NCCN Guidelines for Distress Management recommend that each
new patient be rapidly assessed in the off ce or clinic waiting room for
evidence of distress using the Distress Thermometer and Problem List
as an initial rough screen.171 A score of 4 or greater on the DT should
trigger further evaluation by the oncologist or nurse and referral to a
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Appendix H

Comprehensive Psychosocial Assessment Chart Audit Instrument
Denise Sartz
Chart number:

Date Enrolled in Project:

Demographics:
Gender:

Male

Female

Oncologist:

Batezini

El-Tarabily

Ethnicity:

Caucasian

African American

Language spoken:

English

Spanish

Other

Single

Married

Widowed

Divorced

Em ploym ent status: Retired

Full time

Part time

Unemployed

Prim ary care provider:

Yes

No

Insurance:

Medicare

Medicaid

Private

Living Situation:

Alone

Spouse

Extended Family

Age:

M arital status:

Skilled Nursing Facility
Current Residence: Cheyenne

Religion: Catholic

LDS

Wheatland

Presbyterian

Other
Hispanic

Stage:

II

I

III

Torrington

Lutheran Christian

Unknown

Palliative

Curative

Non-relatives Assisted Living

Laramie

Other

Jewish

None

Other

Not Applicable

Chemotherapy Treatment:
Treatment Goal:

Disabled

Kimball

Year:
IV

Student

Other

Cancer Diagnosis:
Month:

Other

Uninsured

Diagnosis & Treatment History:

Date of Diagnosis:

Asian

Unknown
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Line of Treatment: First

Second

Third

Concomitant Radiation:

Yes

No

Comorbid Conditions: CHF

COPD DM CVA OA

Baseline ECOG performance score:
NCCN Distress Score:
Category:
Practical
Date o f Score:
ECOG: 0
1 2
Intervention:

NCCN Distress Score:
Category:
Practical
Date o f Score:
ECOG: 0
1 2
Intervention:

NCCN Distress Score:
Category:
Practical
Date o f Score:
ECOG: 0
1 2
Intervention:

NCCN Distress Score:
Category:
Practical
Date o f Score:
ECOG: 0
1 2
Intervention:

NCCN Distress Score:
Category:
Practical
Date o f Score:
ECOG: 0
1 2
Intervention:

NCCN Distress Score:
Category:
Practical
Date o f Score:
ECOG: 0
1 2
Intervention:

Fourth

0

Family
3

Unknown

Emotional

Spiritual

Physical

Emotional

Spiritual

Physical

Emotional

Spiritual

Physical

Emotional

Spiritual

Physical

Emotional

Spiritual

Physical

Emotional

Spiritual

Physical

4

Family
3

4

4

Family
3

3

4

Family
3

2

4

Family
3

CAD Other

4

Family
3

1

Five or more

4
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Inform ation and referral interventions provided after DT scores obtained:
HO: Handout (resources available in community) provided
R:
Referral Options: Nurse Practitioner, Hospice, Lymphedema, Nutrition, Psych, Chaplain, Social Worker,
Meals on Wheels, Patient Navigator, Financial Counselor, Palliative Care, Home Care, Wound Care,
Oncologist, Primary Care Physician, PT/OT, Patient Refused Referral, Other

Em ergency Room V isits D uring Treatment:

Yes

No

Dates (if applicable):__________________________________________________________________
Reason:_____________________________________________________________________________

H ospitalizations D uring Treatment:

Yes

No

Dates (if applicable):_________________________________________________________________
Admitting Diagnosis:_________________________________________________________________
Length o f Stay:______________________________________________________________________

Project Status:

Completed

Withdrawn by investigator

Patient Withdrew

Participation Com pletion D a te :________________________________________

Deceased
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Completion Report

Appendix I

Page 1 of 1

CITI C ollaborative Institutional Training Initiative
Human Research C urriculum C om pletion Report
Printed on 7/31/2012
Learner: Denise Sartz (username: denisesartz)
in stitutio n: Regis University
Contact
Department: Nursing
Inform ation
Email: sartz158@ regis.edu
Social Behavioral Research Investigators and Key Personnel:
Stage 1. Basic Course Passed on 07/31/12 (Ref # 8379770)
Required Modules

Date
Completed

Introduction

07/31/12

no quiz

History and Ethical Principles - SBR

07/31/12

4/5 (80%)

The Regulations and The Social and Behavioral
Sciences - SBR

07/31 /12

5/5 (100%)

Assessing Risk in Social and Behavioral Sciences SBR

07/31/12

5/5 (100%)

Informed Consent - SBR

07/31/12

5/5 (100%)

Privacy and Confidentiality - SBR

07/31/12

4/5 (80%)

Regis University

07/31 /12

no quiz

For th is Com pletion Report to be valid, the learner listed above m ust be
affiliated w ith a CITI participating institutio n. Falsified inform ation and
unauthorized use o f the CITI course site is unethical, and may be
considered scie ntific m isconduct by your in stitution.
Paul Braunschweiger Ph.D.
Professor, University of Miami
Director Office o f Research Education
CITI Course Coordinator
Return

https://www.citiprogram.org/members/leamersII/crbystage.asp ?strKeyID=0A3303 88-7106... 7/31/2012
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NEIRB

New England Institutional
Review Board

A ppendix J

January 18, 2013
Denise A. Sartz, MS
Cheyenne Regional Medical Center
214 East 23rd Street
Cheyenne, WY 82001
RE: NEIRB# 13-018: "Screening for Distress in Ambulatory Oncology Patients"

Dear Dr. Sartz:
This is to inform you that New England Institutional Review Board (NEIRB) has reviewed the submission for
the above-captioned project.
NEIRB has determined that this activity, as conducted at the above location, is not seeking to obtain
generalizable knowledge. Therefore, it is not human subjects research and IRB review and approval is not
required.

Please call me if you have any questions about the terms o f this determination

Erin Brower, MS, CIP
Director

Copy: NEIRB Chair

85 Wells Avenue • Suite 107 ' Newton, MA 02459

Phone: 617-243-3924 * Fax:617-969-1310 w w w .neirb.com
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3333 R egis Boulevard, H-4
Denver, C olorado 80221-1099
303-458-4206
303-964-5528 FAX

www.regis.edu

Appendix K
IRB - REGIS UNIVERSITY

February 18,2013
Denise Sartz
2718 Stockbury Drive
Fort Collins, CO 80525
RE:

IRB#: 13-043

Dear Ms. Sartz:
Your application to the Regis IRB for your project “Screening for Distress in Ambulatory
Oncology Patients: The COPE Project” was approved as an exempt study on February 13, 2013.
This study was approved under the 45CFR46.101.b exempt study category #2.
The designation of “exempt,” means no further IRB review o f this project, as it is currently
designed, is needed.
If changes are made in the research plan that significantly alter the involvement of human
subjects from that which was approved in the named application, the new research plan must be
resubmitted to the Regis IRB for approval.
Sincerely,

Patsy McGuire Cullen, PhD, CPNP
Chair, Institutional Review Board
Associate Professor and Director
Department of Accelerated Nursing
Loretto Heights School of Nursing
Rueckert-Hartman College for Health Professions
Regis University

cc: Dr. Diane Ernst

A JESUIT UNIVERSITY
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Appendix L

Cheyenne Regional
Medical Center
214 East 23rd Street
Cheyenne, WY 82001
307'634-2273

January 21, 2013
Institutional Review Board
Regis University
Main Hall, Room 452, Mail Code H4
Denver, CO 80221
Email: irb@regis.edu
RE: Denise Sartz, FNP-C, Doctoral Research
To Whom It May Conccrn;
As the Chief Compliance and Privacy Officer, this letter is to serve as notice that Cheyenne
Regional Medical Center supports the project proposed by Denise Sartz, FNP-C, entitled
“Screening for Distress in Ambulatory Oncology Patients”. Cheyenne Regional is pleased to
support Ms. Sartz in her academic endeavors and we anticipate the results of her research.
For this study, Cheyenne Regional understands that Ms. Sartz will have patients complete a
short questionnaire during each chemotherapy visit and using that information, see if
putting people in touch with resources will improve their overall well-being. This project
has been approved by our outside Institutional Review Board, New England IRB. We
anticipate that if the scope of the study is to change that Ms. Sartz uni I notify Cheyenne
Regional in advance of the change to determine if additional institutional safe guards need
to be followed.
If you have any additional questions or conccrns, please contact Aimee Dendrinos,
Compliance Counsel at (307) 432-6624 or aimee.dendrinos@crmcwv.org.
Thank you,
Carlene Crall
Chief Human Resources Officer
Chief Compliance Officer
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Appendix M
Cheyenne Regional Medical Center
Oncology Product Line
Psychosocial Distress Screening Policy
2012 Standard E10: Psychosocial Distress Screening
Rationale:
Distress (defined): A multifactorial, unpleasant emotional experience o f a psychological
(cognitive, behavioral, emotional), social and/or spiritual nature that may interfere with the
ability to cope effectively with cancer, its physical symptoms and its treatment. Distress extends
along a continuum, ranging from common normal feelings of vulnerability, sadness, and fears to
problems that can becom e disabling, such as depression, anxiety, panic, social isolation, and
existential and spiritual crisis (NCCN, 2012). Oncology patients frequently present with
complex physical needs as well as overwhelming unmet psychosocial concerns. It has been
estimated that 40-50% o f adults with cancer experience clinically significant levels o f distress
(Jacobsen, Donovan, and Trask, 2005). In addition, it has been demonstrated that patients with
heightened distress have poorer treatment outcomes, poorer quality of life and overall poor
satisfaction with care (Jacobsen & Ransom, 2007). In response to these needs the National
Comprehensive Cancer Network (NCCN) issued evidenced-based guidelines to help clinicians
identify, assess, and treat unmet spiritual, psychological, practical, and physical problems.
Policy:
As agreed upon by the Cheyenne Regional Medical Center Cancer Committee, oncology patients
will be screened and assessed for distress utilizing the NCCN Distress Thermometer
(Comprehensive Oncology Patient Experience (COPE) Tool).
All patients will be screened and assessed for distress at their initial visit, at appropriate intervals,
and as clinically indicated, especially when changes occur in disease status (remission,
recurrence, or progression). At a minimum, a baseline assessment will be completed prior to
beginning chemotherapy/radiation therapy and again as deemed clinically necessary.
Procedure:
All oncology patients and their caregivers will be provided information about the psychosocial
services available at Cheyenne Regional Medical Center and within the community.
Clinical evidence o f a moderate to severe distress score (>4) on the NCCN distress thermometer
requires a clinical assessment by a member of the primary oncology team (oncologist, nurse
practitioner, clinical nurse specialist, registered nurse, or social worker). Patients with a
moderate to severe distress score will be referred to a mental health specialist, social worker, or
chaplain depending on the problems identified on the problem list. Distress assessments,
interventions, and referrals are documented in the patient medical record to facilitate integrated,
high quality care by the multi-disciplinary team.

References:
Jacobsen, P., Donovan, K., and Trask, P. (2005). Screening for psychologic distress in
ambulatory care cancer patients. Cancer, 103, 1494-1502.
Jacobsen, P., & Ransom, S. (2007). Implementation o f NCCN distress management guidelines
by member institutions. Journal o f the National Comprehensive Cancer Network, 5, 99-102.
National Comprehensive Cancer Network (2012). Distress management. Version 2.2012.
Retrieved from: www.nccn.org.
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Appendix N

Electronic Health Record Integration

$ COPE Assessment - COPE Assessment Based on Past Week (To be completed monthly)
Time taken: 0810
Responsible

7/18/2013

Create Note

v Psychiatric
Distress
^7 Practical Problems
Child Care

Q 1=Yes

Housing

W ork/School

D
D
D
D

Treatment Decisions

0

2=No

l=Yes

2=No

1=Yes

2=No

1=Yes

2=No

1=Yes

2=No

1=Yes

2=No

1=Yes

2=No

1=Yes

2=No

Ability to have
children

D 1=Yes

2=No

Family health issues

D

2=No

insurance 1 Financial
Transportation

Family Problems
Dealing with children
Dealing with partner

D
D

1=Yes

